Return to More Current References
Older References
-
- Cancer communication research in the era of genomics and precision medicine: a scoping review.
- Kaphingst KA, Peterson E, Zhao J, Gaysynsky A, Elrick A, Hong SJ, Krakow M, Pokharel M, Ratcliff CL, Klein WMP, Khoury MJ, Chou WS.
- Genet Med. 2018 Dec 21. doi: 10.1038/s41436-018-0402-0. [Epub ahead of print]
- PMID: 30573799
- PubMed abstract
- Source abstract
-
- A Systematic Review of the Psychological Implications of Genetic Testing: A Comparative Analysis Among Cardiovascular, Neurodegenerative and Cancer Diseases.
- Oliveri S, Ferrari F, Manfrinati A, Pravettoni G.
- Front Genet. 2018 Dec 10;9:624. doi: 10.3389/fgene.2018.00624.
- PMID: 30619456
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Impact of Appointment Waiting Time on Attendance Rates at a Clinical Cancer Genetics Service.
- Shaw T, Metras J, Ting ZAL, Courtney E, Li ST, Ngeow J.
- J Genet Couns. 2018 Dec;27(6):1473-1481. doi: 10.1007/s10897-018-0259-z. Epub 2018 May 24.
- PMID: 29799102
- PubMed abstract
- Source abstract
-
- Creation and Implementation of an Environmental Scan to Assess Cancer Genetics Services at Three Oncology Care Settings.
- Bednar EM, Walsh MT Jr, Baker E, Muse KI, Oakley HD, Krukenberg RC, Dresbold CS, Jenkinson SB, Eppolito AL, Teed KB, Klein MH, Morman NA, Bowdish EC, Russ P, Wise EE, Cooper JN, Method MW, Henson JW, Grainger AV, Arun BK, Lu KH.
- J Genet Couns. 2018 Dec;27(6):1482-1496. doi: 10.1007/s10897-018-0262-4. Epub 2018 May 24.
- PMID: 29770910
- PubMed abstract
- Source abstract
-
- Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model.
- Pashayan N, Morris S, Gilbert FJ, Pharoah PDP.
- JAMA Oncol. 2018 Nov 1;4(11):1504-1510. doi: 10.1001/jamaoncol.2018.1901.
- PMID: 29978189
- PubMed abstract
Editorial:
Implementation Challenges for Risk-Stratified Screening in the Era of Precision Medicine.
- PMID: 29978191
- PubMed abstract
- Source abstract
Audio Interview: Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Breast Cancer Screening. (JAMA Oncology)
Press: Breast Cancer Screening Only for Women at Higher Risk. (Medscape)
Letter, Comment:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom
Letter, Reply:
Overestimation of the Benefit-to-Harm Ratio of Risk-Based Mammography Screening in the United Kingdom—Reply.
-
- Direct-To-Consumer Genetic Testing: Is the Public Ready for Simple, At-Home DNA Tests to Detect Disease Risk?
- Bates M.
- IEEE Pulse. 2018 Nov-Dec;9(6):11-14. doi: 10.1109/MPUL.2018.2869315.
- PMID: 30452341
- PubMed abstract
- Source abstract
-
- The yield of full BRCA1/2 genotyping in Israeli high-risk breast/ovarian cancer patients who do not carry the predominant mutations.
- Barnes-Kedar I, Bernstein-Molho R, Ginzach N, Hartmajer S, Shapira T, Magal N, Kalis ML, Peretz T, Shohat M, Basel-Salmon L, Friedman E, Bazak L, Goldberg Y.
- Breast Cancer Res Treat. 2018 Nov;172(1):151-157. doi: 10.1007/s10549-018-4887-7. Epub 2018 Jul 16.
- PMID: 30014164
- PubMed abstract
- Source abstract
-
- Contribution of RAD51D germline mutations in breast and ovarian cancer in Greece.
- Konstanta I, Fostira F, Apostolou P, Stratikos E, Kalfakakou D, Pampanos A, Kollia P, Papadimitriou C, Konstantopoulou I, Yannoukakos D.
- J Hum Genet. 2018 Nov;63(11):1149-1158. doi: 10.1038/s10038-018-0498-8. Epub 2018 Aug 15.
- PMID: 30111881
- PubMed abstract
- Source abstract
-
- Cancer genetics program: Follow-up on clinical genetics and genomic medicine in Qatar.
- Al-Bader SB, Alsulaiman R, Bugrein H, Ben Omran T, Abbaszadeh F, Bakheet N, Apsa Kusasi S, Abdou N, Solomon BD, Ghazouani H.
- Mol Genet Genomic Med. 2018 Nov;6(6):865-872. doi: 10.1002/mgg3.534. Epub 2018 Dec 16.
- PMID: 30556325
- PubMed abstract
- Source abstract
- Review, Commentary
- Free PMC article
- Free Full Text
-
- Hereditary Cancer Risk Assessment and Genetic Testing in the Community-Practice Setting.
- DeFrancesco MS, Waldman RN, Pearlstone MM, Karanik D, Bernhisel R, Logan J, Alico L, Adkins RT.
- Obstet Gynecol. 2018 Nov;132(5):1121-1129. doi: 10.1097/AOG.0000000000002916.
- PMID: 30303907
- PubMed abstract
- Source abstract
-
- Genetic Testing and Clinical Management Practices for Variants in Non-BRCA1/2 Breast (and Breast/Ovarian) Cancer Susceptibility Genes: An International Survey by the Evidence-Based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) Clinical Working Group.
- Nielsen SM, Eccles DM, Romero IL, Al-Mulla F, Balmaña J, Biancolella M, Bslok R, Caligo MA, Calvello M, Capone GL, Cavalli P, Chan TLC, Claes KBM, Cortesi L, Couch FJ, de la Hoya M, De Toffol S, Diez O, Domchek SM, Eeles R, Efremidis A, Fostira F, Goldgar D, Hadjisavvas A, Hansen TVO, Hirasawa A, Houdayer C, Kleiblova P, Krieger S, Lázaro C, Loizidou M, Manoukian S, Mensenkamp AR, Moghadasi S, Monteiro AN, Mori L, Morrow A, Naldi N, Nielsen HR, Olopade OI, Pachter NS, Palmero EI, Pedersen IS, Piane M, Puzzo M, Robson M, Rossing M, Sini MC, Solano A, Soukupova J, Tedaldi G, Teixeira M, Thomassen M, Tibiletti MG, Toland A, Törngren T, Vaccari E, Varesco L, Vega A, Wallis Y, Wappenschmidt B, Weitzel J, Spurdle AB, De Nicolo A, Gómez-García EB.
- JCO Precis Oncol. 2018;2. doi: 10.1200/PO.18.00091. Epub 2018 Oct 26.
- PMID: 31517176
- PubMed abstract
-
- Identification of Incidental Germline Mutations in Patients With Advanced Solid Tumors Who Underwent Cell-Free Circulating Tumor DNA Sequencing.
- Slavin TP, Banks KC, Chudova D, Oxnard GR, Odegaard JI, Nagy RJ, Tsang KWK, Neuhausen SL, Gray SW, Cristofanilli M, Rodriguez AA, Bardia A, Leyland-Jones B, Janicek MF, Lilly M, Sonpavde G, Lee CE, Lanman RB, Meric-Bernstam F, Kurzrock R, Weitzel JN.
- J Clin Oncol. 2018 Oct 19:JCO1800328. doi: 10.1200/JCO.18.00328. [Epub ahead of print]
- PMID: 30339520
- PubMed abstract
- Source abstract
-
- Knowledge regarding and patterns of genetic testing in patients newly diagnosed with breast cancer participating in the iCanDecide trial.
- Gornick MC, Kurian AW, An LC, Fagerlin A, Jagsi R, Katz SJ, Hawley ST.
- Cancer. 2018 Oct 15;124(20):4000-4009. doi: 10.1002/cncr.31731. Epub 2018 Oct 5.
- PMID: 30289174
- PubMed abstract
- Source abstract
-
- Ethical Implications of Direct-to-Consumer Hereditary Cancer Tests.
- Kilbride MK, Domchek SM, Bradbury AR.
- JAMA Oncol. 2018 Oct 1;4(10):1327-1328. doi: 10.1001/jamaoncol.2018.2439.
- PMID: 30027223
- PubMed abstract
- Source abstract
-
- Frequency of Germline Mutations in Cancer Susceptibility Genes in Malignant Mesothelioma.
- Panou V, Gadiraju M, Wolin A, Weipert CM, Skarda E, Husain AN, Patel JD, Rose B, Zhang SR, Weatherly M, Nelakuditi V, Knight Johnson A, Helgeson M, Fischer D, Desai A, Sulai N, Ritterhouse L, Røe OD, Turaga KK, Huo D, Segal J, Kadri S, Li Z, Kindler HL, Churpek JE.
- J Clin Oncol. 2018 Oct 1;36(28):2863-2871. doi: 10.1200/JCO.2018.78.5204. Epub 2018 Aug 16.
- PMID: 30113886
- PubMed abstract
- Source abstract
-
- Mutations in context: implications of BRCA testing in diverse populations.
- Felix GES, Zheng Y, Olopade OI.
- Fam Cancer. 2018 Oct;17(4):471-483. doi: 10.1007/s10689-017-0038-2.
- PMID: 28918466
- PubMed abstract
- Source abstract
-
- Personalised medicine and population health: breast and ovarian cancer.
- Narod SA.
- Hum Genet. 2018 Oct;137(10):769-778. doi: 10.1007/s00439-018-1944-6. Epub 2018 Oct 17.
- PMID: 30328515
- PubMed abstract
- Source abstract
Letter, Commentary:
A response to "Personalised medicine and population health: breast and ovarian cancer".
- PMID: 30810870
- PubMed abstract
- Source abstract
Letter, Reply:
Author response to “a response to ‘personalised medicine and population health: breast and ovarian cancer’”.
- PMID: 30790050
- PubMed abstract
- Source abstract
-
- Changing landscape of hereditary breast and ovarian cancer germline genetic testing in Australia.
- Petelin L, James PA, Trainer AH.
- Intern Med J. 2018 Oct;48(10):1269-1272. doi: 10.1111/imj.14058.
- PMID: 30288903
- PubMed abstract
- Source abstract
-
- Direct-to-consumer genetic testing for breast cancer risk.
- Reed EK, Edelman EA.
- J Am Assoc Nurse Pract. 2018 Oct;30(10):548-550. doi: 10.1097/JXX.0000000000000146.
- PMID: 30320707
- PubMed abstract
- Source abstract
-
- Prevalence of Variant Reclassification Following Hereditary Cancer Genetic Testing.
- Mersch J, Brown N, Pirzadeh-Miller S, Mundt E, Cox HC, Brown K, Aston M, Esterling L, Manley S, Ross T.
- JAMA. 2018 Sep 25;320(12):1266-1274. doi: 10.1001/jama.2018.13152.
- PMID: 30264118
- PubMed abstract
- Source abstract
Editorial:
Making Sense of the Genome Remains a Work in Progress
- PMID: 30264098
- PubMed abstract
- Source abstract
Editorial:
Multitiered Questions Regarding Multigene Testing for Cancer Susceptibility.
- PMID: 30264135
- PubMed abstract
- Source abstract
-
- A feasibility study of breast cancer genetic risk assessment in a federally qualified health center.
- Hoskins KF, Tejeda S, Vijayasiri G, Chukwudozie IB, Remo MH, Shah HA, Abraham IE, Balay LE, Maga TK, Searles ER, Korah VJ, Biggers A, Stolley MR, Warnecke RB.
- Cancer. 2018 Sep 15;124(18):3733-3741. doi: 10.1002/cncr.31635. Epub 2018 Oct 15.
- PMID: 30320429
- PubMed abstract
- Source abstract
-
- Rapid detection of copy number variations and point mutations in BRCA1/2 genes using a single workflow by ion semiconductor sequencing pipeline.
- Germani A, Libi F, Maggi S, Stanzani G, Lombardi A, Pellegrini P, Mattei M, De Marchis L, Amanti C, Pizzuti A, Torrisi MR, Piane M.
- Oncotarget. 2018 Sep 14;9(72):33648-33655. doi: 10.18632/oncotarget.26000. eCollection 2018 Sep 14.
- PMID: 30263092
- PubMed abstract
- Source abstract
-
- How are genetic test results being used by Australian life insurers?
- Barlow-Stewart K, Liepins M, Doble A, Otlowski M.
- Eur J Hum Genet. 2018 Sep;26(9):1248-1256. doi: 10.1038/s41431-018-0198-z. Epub 2018 Jun 11.
- PMID: 29891881
- PubMed abstract
-
- Proposed outcomes measures for state public health genomic programs.
- Doyle DL, Clyne M, Rodriguez JL, Cragun DL, Senier L, Hurst G, Chan K, Chambers DA.
- Genet Med. 2018 Sep;20(9):995-1003. doi: 10.1038/gim.2017.229. Epub 2018 Jan 4.
- PMID: 29300382
- PubMed abstract
Original research:
Implementing Cancer Genomics in State Health Agencies: Mapping Activities to an Implementation Science Outcome Framework.
- PMID: 32942283
- PubMed abstract
- Source abstract
-
- Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing.
- Chadwell SE, He H, Knapke S, Lewis J, Sisson R, Hopper J.
- J Genet Couns. 2018 Sep;27(5):1210-1219. doi: 10.1007/s10897-018-0241-9. Epub 2018 Mar 17.
- PMID: 29550970
- PubMed abstract
- Source abstract
-
- How Should Genetic Counseling for Ovarian Cancer Be Implemented in a Middle-Income Country? An Insight Based on the Brazilian Scenario.
- Koike Folgueira MAA, Maistro S, Teixeira N, Mourits MJE, Chammas R, Hendrika de Bock G.
- J Glob Oncol. 2018 Sep;4:1-3. doi: 10.1200/JGO.17.00230.
- PMID: 30241261
- PubMed abstract
- Source abstract
- Commentary
- Free PMC article
- Free Full Text
-
- Cancer genetics, precision prevention and a call to action.
- Turnbull C, Sud A, Houlston RS
- Nat Genet. 2018 Sep;50(9):1212-1218. doi: 10.1038/s41588-018-0202-0. Epub 2018 Aug 29.
- PMID: 30158684
- PubMed abstract
- Source abstract
Editorial:
GPS for navigating healthcare.
- PMID: 30158687
- PubMed abstract
- Free Full Text
-
- BRCA1 and BRCA2 Mutations Other Than the Founder Alleles Among Ashkenazi Jewish in the Population of Argentina.
- Solano AR, Liria NC, Jalil FS, Faggionato DM, Mele PG, Mampel A, Cardoso FC, Podesta EJ.
- Front Oncol. 2018 Aug 21;8:323. doi: 10.3389/fonc.2018.00323. eCollection 2018.
- PMID: 30186769
- PubMed abstract
-
- Homologous recombination deficiency in ovarian cancer: a review of its epidemiology and management.
- da Cunha Colombo Bonadio RR, Fogace RN, Miranda VC, Diz MDPE.
- Clinics (Sao Paulo). 2018 Aug 20;73(suppl 1):e450s. doi: 10.6061/clinics/2018/e450s.
- PMID: 30133561
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- MAGENTA Study Aims to Find Best Genetic Counseling Method for Online Cancer Risk Testing.
- Ray T.
- Precision Oncology News. Disease Areas. Cancer. 2018 Aug 4.
Identifier: NCT02993068: Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible). (ClinicalTrials.gov)
-
- Genetic testing for hereditary prostate cancer: Current status and limitations.
- Zhen JT, Syed J, Nguyen KA, Leapman MS, Agarwal N, Brierley K, Llor X, Hofstatter E, Shuch B.
- Cancer. 2018 Aug 1;124(15):3105-3117. doi: 10.1002/cncr.31316. Epub 2018 Apr 18.
- PMID: 29669169
- PubMed abstract
- Source abstract
-
- Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit.
- Lobo M, López-Tarruella S, Luque S, Lizarraga S, Flores-Sánchez C, Bueno O, Solera J, Jerez Y, Del Val RG, Palomero MI, Cebollero M, Echavarría I, Torres G, Martín M, Márquez-Rodas I.
- J Genet Couns. 2018 Aug;27(4):854-862. doi: 10.1007/s10897-017-0187-3. Epub 2017 Dec 15.
- PMID: 29247312
- PubMed abstract
- Source abstract
-
- Current detection rates and time-to-detection of all identifiable BRCA carriers in the Greater London population.
- Manchanda R, Blyuss O, Gaba F, Gordeev VS, Jacobs C, Burnell M, Gan C, Taylor R, Turnbull C, Legood R, Zaikin A, Antoniou AC, Menon U, Jacobs I.
- J Med Genet. 2018 Aug;55(8):538-545. doi: 10.1136/jmedgenet-2017-105195. Epub 2018 Apr 5.
- PMID: 29622727
- PubMed abstract
- Source abstract
-
- Breast Cancer Genetics and Indications for Prophylactic Mastectomy.
- Krontiras H, Farmer M, Whatley J.
- Surg Clin North Am. 2018 Aug;98(4):677-685. doi: 10.1016/j.suc.2018.03.004. Epub 2018 May 30.
- PMID: 30005767
- PubMed abstract
- Source abstract
-
- BRCA1 founder mutations and beyond in the Polish population: A single-institution BRCA1/2 next-generation sequencing study.
- Kowalik A, Siołek M, Kopczyński J, Krawiec K, Kalisz J, Zięba S, Kozak-Klonowska B, Wypiórkiewicz E, Furmańczyk J, Nowak-Ozimek E, Chłopek M, Macek P, Smok-Kalwat J, Góźdź S.
- PLoS One. 2018 Jul 24;13(7):e0201086. doi: 10.1371/journal.pone.0201086. eCollection 2018.
- PMID: 30040829
- PubMed abstract
-
- BRCA1 c.68_69delAG (exon2), c.181T>G (exon5), c.798_799delTT and 943ins10 (exon11) mutations in Burkina Faso.
- Zoure AA, Slaoui M, Bambara HA, Sawadogo AY, Compaoré TR, Ouédraogo NLM, Mzibri ME, Attaleb M, Traoré SS, Simpore J, Bakri Y.
- J Public Health Afr. 2018 Jul 6;9(1):663. doi: 10.4081/jphia.2018.663. eCollection 2018 May 21.
- PMID: 30079159
- PubMed abstract
- Source abstract
-
- Cost-effectiveness evaluation of pre-counseling telephone interviews before face-to-face genetic counseling in cancer genetics.
- Collet G, Parodi N, Cassinari K, Neviere Z, Cohen F, Gasnier C, Brahimi A, Lecoquierre F, Thery JC, Tennevet I, Lacaze E, Berthet P, Frebourg T.
- Fam Cancer. 2018 Jul;17(3):451-457. doi: 10.1007/s10689-017-0049-z.
- PMID: 29080081
- PubMed abstract
- Source abstract
-
- Germline mutations in BRCA1 and BRCA2 incidentally revealed in a biobank research study: experiences from re-contacting mutation carriers and relatives.
- Nilsson MP, Emmertz M, Kristoffersson U, Borg Å, Larsson C, Rehn M, Winter C, Saal LH, Brandberg Y, Loman N.
- J Community Genet. 2018 Jul;9(3):201-208. doi: 10.1007/s12687-017-0341-5. Epub 2017 Oct 30.
- PMID: 29082482
- PubMed abstract
-
- A comparison of cancer risk assessment and testing outcomes in patients from underserved vs. tertiary care settings.
- Rana HQ, Cochrane SR, Hiller E, Akindele RN, Nibecker CM, Svoboda LA, Cronin AM, Garber JE, Lathan CS.
- J Community Genet. 2018 Jul;9(3):233-241. doi: 10.1007/s12687-017-0347-z. Epub 2017 Nov 18.
- PMID: 29151150
- PubMed abstract
- Source abstract
-
- Clinical Cancer Genetics in a Lower-Middle Income Country: Considerations for Policymaking.
- Ginsburg O, Narod SA.
- J Glob Oncol. 2018 Jul;(4):1-3. doi: 10.1200/JGO.18.00081.
- PMID: 30084717
- PubMed abstract
- Source abstract
- Editorial
- Free Full Text
Knowledge of Genetic Counseling Among Patients With Breast Cancer and Their Relatives at a Nigerian Teaching Hospital.
- PMID: 30084716
- PubMed abstract
- Free Full Text
-
- Evaluation of some direct-to-consumer genetic testing reveals inaccuracies and misinterpretations.
- [No author given]
- FORCE. XRAYS. 2018 Jun 28.
- Research news
- Free Full Text
False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.
- PMID: 29565420
- PubMed abstract
- Free Full Text
-
- Direct-to-Consumer Genetic Testing: The Implications of the US FDA's First Marketing Authorization for BRCA Mutation Testing.
- Gill J, Obley AJ, Prasad V.
- JAMA. 2018 Jun 19;319(23):2377-2378. doi: 10.1001/jama.2018.5330.
- PMID: 29800087
- PubMed abstract
- Source abstract
-
- 5-year BRCA SCOTUS Anniversary.
- [No author given]
- My Gene Counsel. 2018 Jun 13.
- Blog post
- Free Full Text
-
- The ICR639 CPG NGS validation series: A resource to assess analytical sensitivity of cancer predisposition gene testing.
- Mahamdallie S, Ruark E, Holt E, Poyastro-Pearson E, Renwick A, Strydom A, Seal S, Rahman N.
- Wellcome Open Res. 2018 Jun 12;3:68. doi: 10.12688/wellcomeopenres.14594.1. eCollection 2018.
- PMID: 30175241
- PubMed abstract
-
- [Chinese consensus on next generation sequencing-based BRCA testing].
- Working group of Chinese consensus on next generation sequencing-based BRCA testing.
- Zhonghua Bing Li Xue Za Zhi. 2018 Jun 8;47(6):401-406. doi: 10.3760/cma.j.issn.0529-5807.2018.06.003.
- PMID: 29886581
- PubMed abstract
-
- Previvor: An Oncology Nurse's Story of Cancer Risk Reduction Through Genetic Testing.
- Kelly J.
- Clin J Oncol Nurs. 2018 Jun 1;22(3):247-248. doi: 10.1188/18.CJON.247-248.
- PMID: 29781468
- PubMed abstract
- Source abstract
-
- National Distribution of Cancer Genetic Testing in the United States: Evidence for a Gender Disparity in Hereditary Breast and Ovarian Cancer.
- Childers KK, Maggard-Gibbons M, Macinko J, Childers CP.
- JAMA Oncol. 2018 Jun 1;4(6):876-879. doi: 10.1001/jamaoncol.2018.0340.
- PMID: 29710084
- PubMed abstract
- Source abstract
-
- Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia.
- Lim KK, Yoon SY, Mohd Taib NA, Shabaruddin FH, Dahlui M, Woo YL, Thong MK, Teo SH, Chaiyakunapruk N.
- Appl Health Econ Health Policy. 2018 Jun;16(3):395-406. doi: 10.1007/s40258-018-0384-8.
- PMID: 29572724
- PubMed abstract
- Source abstract
-
- Screening for founder and recurrent BRCA mutations in Hong Kong and US Chinese populations.
- Kwong A, Shin VY, Ma ES, Chan CT, Ford JM, Kurian AW, Tai E.
- Hong Kong Med J. 2018 Jun;24 Suppl 3(3):4-6.
- PMID: 29937436
- PubMed abstract
- Source abstract
-
- [To know or not to know, that is the question - screening for BRCA].
- Johannsson OT.
- Laeknabladid. 2018 Jun;104(6):281. doi: 10.17992/lbl.2018.06.187.
- PMID: 29863481
- PubMed abstract
- Editorial, [Article in Icelandic]
- Free Full Text [Icelandic]
-
- [Views of Icelandic women towards genetic counseling - and testing of BRCA2 mutations].
- Jonsdottir T, Valdimarsdottir H, Tryggvadottir L, Lund SH, Thordardottir M, Magnusson MK, Valdimarsdottir U.
- Laeknabladid. 2018 Jun;104(6):289-296. doi: 10.17992/lbl.2018.06.189.
- PMID: 29863481
- PubMed abstract
- [Article in Icelandic]
- Free Full Text [Icelandic]
-
- Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
- Møller P, Hovig E.
- Med Health Care Philos. 2018 Jun;21(2):239-242. doi: 10.1007/s11019-017-9803-0.
- PMID: 28939999
- PubMed abstract
- Commentary
- Free Full Text
Our genes, our selves: hereditary breast cancer and biological citizenship in Norway.
- PMID: 27709396
- PubMed abstract
- Source abstract
Commentary, Reply:
Scientific supremacy as an obstacle to establishing and sustaining interdisciplinary dialogue across knowledge paradigms in health medicine.
- PMID: 31025263
- PubMed abstract
- Free Full Text
-
- Effects of Cancer Genetic Panel Testing on at-Risk Individuals.
- Frost AS, Toaff M, Biagi T, Stark E, McHenry A, Kaltman R.
- Obstet Gynecol. 2018 Jun;131(6):1103-1110. doi: 10.1097/AOG.0000000000002531.
- PMID: 29742654
- PubMed abstract
- Source abstract
-
- Pervasive genetic testing.
- Thiruchelvam PTR, Fisher CS, Leff DR, Domchek SM.
- Lancet. 2018 May 26;391(10135):2089-2091. doi: 10.1016/S0140-6736(18)30997-8. Epub 2018 May 24.
- PMID: 29856334
- PubMed abstract
- Source abstract
-
- Practical Methods for Integrating Genetic Testing Into Clinical Practice for Advanced Prostate Cancer.
- Cheng H, Powers J, Schaffer K, Sartor O.
- Am Soc Clin Oncol Educ Book. 2018 May 23;(38):372-381. doi: 10.1200/EDBK_205441.
- PMID: 30231311
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Impact of an embedded genetic counselor on breast cancer treatment.
- Pederson HJ, Hussain N, Noss R, Yanda C, O'Rourke C, Eng C, Grobmyer SR.
- Breast Cancer Res Treat. 2018 May;169(1):43-46. doi: 10.1007/s10549-017-4643-4. Epub 2018 Jan 18.
- PMID: 29349711
- PubMed abstract
- Source abstract
-
- Direct-to-Consumer Test for BRCA Mutations Authorized.
- [No authors listed]
- Cancer Discov. 2018 May;8(5):OF5. doi: 10.1158/2159-8290.CD-NB2018-031. Epub 2018 Mar 14.
- PMID: 29540360
- PubMed abstract
- Source abstract
-
- Risk, Prediction and Prevention of Hereditary Breast Cancer - Large-Scale Genomic Studies in Times of Big and Smart Data.
- Wunderle M, Olmes G, Nabieva N, Häberle L, Jud SM, Hein A, Rauh C, Hack CC, Erber R, Ekici AB, Hoyer J, Vasileiou G, Kraus C, Reis A, Hartmann A, Schulz-Wendtland R, Lux MP, Beckmann MW, Fasching PA.
- Geburtshilfe Frauenheilkd. 2018 May;78(5):481-492. doi: 10.1055/a-0603-4350. Epub 2018 Jun 4.
- PMID: 29880983
- PubMed abstract
- Source abstract
- Review
- Free PMC article
- Free Full Text
-
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations.
- Rebbeck TR, Friebel TM, Friedman E, Hamann U, Huo D, Kwong A, Olah E, Olopade OI, Solano AR, Teo SH, Thomassen M, Weitzel JN, Chan TL, Couch FJ, Goldgar DE, Kruse TA, Palmero EI, Park SK, Torres D, van Rensburg EJ, McGuffog L, Parsons MT, Leslie G, Aalfs CM, Abugattas J, Adlard J, Agata S, Aittomäki K, Andrews L, Andrulis IL, Arason A, Arnold N, Arun BK, Asseryanis E, Auerbach L, Azzollini J, Balmaña J, Barile M, Barkardottir RB, Barrowdale D, Benitez J, Berger A, Berger R, Blanco AM, Blazer KR, Blok MJ, Bonadona V, Bonanni B, Bradbury AR, Brewer C, Buecher B, Buys SS, Caldes T, Caliebe A, Caligo MA, Campbell I, Caputo SM, Chiquette J, Chung WK, Claes KBM, Collée JM, Cook J, Davidson R, de la Hoya M, De Leeneer K, de Pauw A, Delnatte C, Diez O, Ding YC, Ditsch N, Domchek SM, Dorfling CM, Velazquez C, Dworniczak B, Eason J, Easton DF, Eeles R, Ehrencrona H, Ejlertsen B; EMBRACE, Engel C, Engert S, Evans DG, Faivre L, Feliubadaló L, Ferrer SF, Foretova L, Fowler J, Frost D, Galvão HCR, Ganz PA, Garber J, Gauthier-Villars M, Gehrig A; GEMO Study Collaborators, Gerdes AM, Gesta P, Giannini G, Giraud S, Glendon G, Godwin AK, Greene MH, Gronwald J, Gutierrez-Barrera A, Hahnen E, Hauke J; HEBON, Henderson A, Hentschel J, Hogervorst FBL, Honisch E, Imyanitov EN, Isaacs C, Izatt L, Izquierdo A, Jakubowska A, James P, Janavicius R, Jensen UB, John EM, Vijai J, Kaczmarek K, Karlan BY, Kast K, Investigators K, Kim SW, Konstantopoulou I, Korach J, Laitman Y, Lasa A, Lasset C, Lázaro C, Lee A, Lee MH, Lester J, Lesueur F, Liljegren A, Lindor NM, Longy M, Loud JT, Lu KH, Lubinski J, Machackova E, Manoukian S, Mari V, Martínez-Bouzas C, Matrai Z, Mebirouk N, Meijers-Heijboer HEJ, Meindl A, Mensenkamp AR, Mickys U, Miller A, Montagna M, Moysich KB, Mulligan AM, Musinsky J, Neuhausen SL, Nevanlinna H, Ngeow J, Nguyen HP, Niederacher D, Nielsen HR, Nielsen FC, Nussbaum RL, Offit K, Öfverholm A, Ong KR, Osorio A, Papi L, Papp J, Pasini B, Pedersen IS, Peixoto A, Peruga N, Peterlongo P, Pohl E, Pradhan N, Prajzendanc K, Prieur F, Pujol P, Radice P, Ramus SJ, Rantala J, Rashid MU, Rhiem K, Robson M, Rodriguez GC, Rogers MT, Rudaitis V, Schmidt AY, Schmutzler RK, Senter L, Shah PD, Sharma P, Side LE, Simard J, Singer CF, Skytte AB, Slavin TP, Snape K, Sobol H, Southey M, Steele L, Steinemann D, Sukiennicki G, Sutter C, Szabo CI, Tan YY, Teixeira MR, Terry MB, Teulé A, Thomas A, Thull DL, Tischkowitz M, Tognazzo S, Toland AE, Topka S, Trainer AH, Tung N, van Asperen CJ, van der Hout AH, van der Kolk LE, van der Luijt RB, Van Heetvelde M, Varesco L, Varon-Mateeva R, Vega A, Villarreal-Garza C, von Wachenfeldt A, Walker L, Wang-Gohrke S, Wappenschmidt B, Weber BHF, Yannoukakos D, Yoon SY, Zanzottera C, Zidan J, Zorn KK, Hutten Selkirk CG, Hulick PJ, Chenevix-Trench G, Spurdle AB, Antoniou AC, Nathanson KL.
- Hum Mutat. 2018 May;39(5):593-620. doi: 10.1002/humu.23406. Epub 2018 Mar 12.
- PMID: 29446198
- PubMed abstract
- Source abstract
-
- Hereditary Cancer Genetic Testing in Community-Based Obstetrics and Gynecology Settings.
- Obstet Gynecol. 2018 May;131(5):119s. doi: 10.1097/01.AOG.0000533506.01865.a1.
-
- Risk Screening for Hereditary Cancer During Obstetrical Care: Barriers to Testing and Health Disparities.
- Lua LL, Jackson D, Foggia M, Rosenbaum A.
- Obstet Gynecol. 2018 May;131(Suppl 1):148s. doi: 10.1097/01.AOG.0000533083.79347.8c.
-
- Systematic review of the empirical investigation of resources to support decision-making regarding BRCA1 and BRCA2 genetic testing in women with breast cancer.
- Grimmett C, Pickett K, Shepherd J, Welch K, Recio-Saucedo A, Streit E, Seers H, Armstrong A, Cutress RI, Evans DG, Copson E, Meiser B, Eccles D, Foster C.
- Patient Educ Couns. 2018 May;101(5):779-788. doi: 10.1016/j.pec.2017.11.016. Epub 2017 Nov 26.
- PMID: 29225062
- PubMed abstract
- Source abstract
-
- Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.
- Park S, Lee JE, Ryu JM, Kim I, Bae SY, Lee SK, Yu J, Kim SW, Nam SJ.
- World J Surg. 2018 May;42(5):1384-1390. doi: 10.1007/s00268-017-4342-7.
- PMID: 29147896
- PubMed abstract
- Source abstract
-
- Trends in utilization and costs of BRCA testing among women aged 18-64 years in the United States, 2003-2014.
- Chen Z, Kolor K, Grosse SD, Rodriguez JL, Lynch JA, Green RF, Dotson WD, Bowen MS, Khoury MJ.
- Genet Med. 2018 Apr;20(4):428-434. doi: 10.1038/gim.2017.118. Epub 2017 Sep 21.
- PMID: 28933789
- PubMed abstract
- Source abstract
-
- Disparities in genetics assessment for women with ovarian cancer: Can we do better?
- Manrriquez E, Chapman JS, Mak J, Blanco AM, Chen LM.
- Gynecol Oncol. 2018 Apr;149(1):84-88. doi: 10.1016/j.ygyno.2017.10.034.
- PMID: 29605055
- PubMed abstract
- Source abstract
-
- False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care.
- Tandy-Connor S, Guiltinan J, Krempely K, LaDuca H, Reineke P, Gutierrez S, Gray P, Tippin Davis B.
- Genet Med. 2018 Mar 22. doi: 10.1038/gim.2018.38. [Epub ahead of print]
- PMID: 29565420
- PubMed abstract
Commentary:
Attention: Direct-To-Consumer patrons: Proceed with caution.
- PMID: 29713001
- PubMed abstract
- Source abstract
Research news: Evaluation of some direct-to-consumer genetic testing reveals inaccuracies and misinterpretations (FORCE. XRAYS.)
Press: Wrangle Over DTC Results—Ambry Study Highlights 40% False Positives, 23andMe Defends Tests, and Experts Weigh In. (Clinical OMICs)
Press: Ambry and My Gene Counsel Team Up on Tests to Confirm DTC Results, Counseling. (Clinical OMICs)
-
- The Right Not to Know: When Ignorance Is Bliss but Deadly.
- Clausen AM.
- Global Health NOW. 2018 Mar 20.
Commentary: The right not to know when not knowing is dangerous. (FORCE. XRAYS.)
-
- FDA approves breast cancer test kits: how useful are they?
- [No author given]
- FORCE. XRAYS. 2018 Mar 19.
- News
- Free Full Text
FDA News Release: FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes (U.S. Food & Drug Administration)
Press: Oncology Community Sees Potential for Patient Harm in FDA OK of 23andMe BRCA Test (GenomeWeb)
Press: FDA Authorizes 23andMe DTC Test Report for Three BRCA Mutations (GenomeWeb)
-
- Medical Strategy or Marketing Strategy?
- Resta R.
- The DNA Exchange. 2018 Mar 18.
- Blog post
- Free Full Text
-
- Factors Influencing Clinical Follow-Up for Individuals with a Personal History of Breast and/or Ovarian Cancer and Previous Uninformative BRCA1 and BRCA2 Testing.
- Chadwell SE, He H, Knapke S, Lewis J, Sisson R, Hopper J.
- J Genet Couns. 2018 Mar 17. doi: 10.1007/s10897-018-0241-9. [Epub ahead of print]
-
- First DTC Test for Some BRCA Mutations Authorized by FDA.
- Nelson R.
- Medscape. Medscape Medical News. 2018 Mar 7.
-
- NSGC Responds to U.S. Food and Drug Administration Approval of Direct-to-Consumer Cancer Test that Reports Three BRCA Mutations.
- [No author given]
- NSGC blog, 2018 Mar 6.
- Blog post, News
- Free Full Text
FDA News Release: FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes (U.S. Food & Drug Administration)
-
- FDA authorizes, with special controls, direct-to-consumer test that reports three mutations in the BRCA breast cancer genes.
- [No author given]
- U.S. Food & Drug Administration. FDA News Release. 2018 Mar 6.
Blog post, News: NSGC Responds to U.S. Food and Drug Administration Approval of Direct-to-Consumer Cancer Test that Reports Three BRCA Mutations (NSGC Blog)
News: FDA approves breast cancer test kits: how useful are they? (FORCE. XRAYS)
-
- Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
- Eisen A, Blackmore KM, Meschino WS, Muradali D, Carroll JC, Majpruz V, Warner E, Rabeneck L, Chiarelli AM.
- Mol Genet Genomic Med. 2018 Mar;6(2):213-223. doi: 10.1002/mgg3.359. Epub 2018 Jan 25.
- PMID: 29368425
- PubMed abstract
- Source abstract
-
- The changing landscape of hereditary cancer genetic testing.
- Webster RD, Ross JL, Arun BK
- Cancer. 2018 Feb 15;124(4):664-666. doi: 10.1002/cncr.31185. Epub 2017 Dec 19.
- PMID: 29266190
- PubMed abstract
- Source abstract
-
- Clinical testing of BRCA1 and BRCA2: a worldwide snapshot of technological practices.
- Toland AE, Forman A, Couch FJ, Culver JO, Eccles DM, Foulkes WD, Hogervorst FBL, Houdayer C, Levy-Lahad E, Monteiro AN, Neuhausen SL, Plon SE, Sharan SK, Spurdle AB, Szabo C, Brody LC; BIC Steering Committee.
- NPJ Genom Med. 2018 Feb 15;3:7. doi: 10.1038/s41525-018-0046-7. eCollection 2018.
- PMID: 29479477
- PubMed abstract
-
- Genetic Testing: Multiple Problems to Solve.
- Ramos E, Haidle JL.
- J Clin Oncol. 2018 Feb 10;36(5):518-519. doi: 10.1200/JCO.2017.76.0942. Epub 2018 Jan 2.
- PMID: 29293389
- PubMed abstract
- Letter, Comment
- Free Full Text
Editorial:
Genetic Testing: What Problem Are We Trying to Solve?
- PMID: 28820645
- PubMed abstract
- Free Full Text
Letter, Reply:
Reply to E. Ramos et al.
- PMID: 29293390
- PubMed abstract
- Source abstract
-
- BRCAsearch: written pre-test information and BRCA1/2 germline mutation testing in unselected patients with newly diagnosed breast cancer.
- Nilsson MP, Törngren T, Henriksson K, Kristoffersson U, Kvist A, Silfverberg B, Borg Å, Loman N.
- Breast Cancer Res Treat. 2018 Feb;168(1):117-126. doi: 10.1007/s10549-017-4584-y. Epub 2017 Nov 21.
- PMID: 29164420
- PubMed abstract
-
- Examination of the Patient-Focused Impact of Cancer Telegenetics Among a Rural Population: Comparison with Traditional In-Person Services.
- Solomons NM, Lamb AE, Lucas FL, McDonald EF, Miesfeldt S.
- Telemed J E Health. 2018 Feb;24(2):130-138. doi: 10.1089/tmj.2017.0073. Epub 2017 Jul 21.
- PMID: 28737998
- PubMed abstract
- Source abstract
-
- Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.
- Peterson EB, Chou WS, Gaysynsky A, Krakow M, Elrick A, Khoury MJ, Kaphingst KA.
- Transl Behav Med. 2018 Jan 29;8(1):59-70. doi: 10.1093/tbm/ibx063.
- PMID: 29385592
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- The risk of unjustified BRCA testing after the "Angelina Jolie effect": how can we save (laboratory) medicine from the Internet?
- Lippi G.
- Clin Chem Lab Med. 2018 Jan 26;56(2):e33-e35. doi: 10.1515/cclm-2017-0551.
- PMID: 28753535
- PubMed abstract
- Source abstract
-
- Genetic Testing for Hereditary Breast Cancer: The Decision to Decline.
- White VB, Walsh KK, Foss KS, Amacker-North L, Lenarcic S, McNeely L, White RL Jr..
- Am Surg. 2018 Jan 1;84(1):154-160.
- PMID: 29428045
- PubMed abstract
- Source abstract
-
- Surveillance report 2018 – Familial breast cancer: classification, care and managing breast cancer and related risks in people with a family history of breast cancer (2013) NICE guideline CG164 [Internet].
- NICE Surveillance programme project team: Nolan K, Allaby M, McFarlane E, Murray A.
- London: National Institute for Health and Care Excellence (UK); 2018 Jan.
- PMID: 31909932
- PubMed abstract
- Guidelines, Book
- Free Full Text
-
- Considerations in Testing for Inherited Breast Cancer Predisposition in the Era of Personalized Medicine.
- Powers B, Pal T, Laronga C.
- Surg Oncol Clin N Am. 2018 Jan;27(1):1-22. doi: 10.1016/j.soc.2017.08.003.
- PMID: 29132555
- PubMed abstract
- Source abstract
-
- Rapid screening test of most frequent BRCA1/BRCA2 pathogenic variants in the NGS era.
- Zidekova D, Waczulikova I, Dolesova L, Vavrova L, Hamidova O, Lohajova Behulova R, Konecny M.
- Neoplasma. 2018;65(2):309-315. doi: 10.4149/neo_2018_170507N328.
- PMID: 29534594
- PubMed abstract
- Source abstract
-
- National Estimates of Genetic Testing in Women With a History of Breast or Ovarian Cancer.
- Childers CP, Childers KK, Maggard-Gibbons M, Macinko J.
- J Clin Oncol. 2017 Dec 1;35(34):3800-3806. doi: 10.1200/JCO.2017.73.6314. Epub 2017 Aug 18.
- PMID: 28820644
- PubMed abstract
- Source abstract
Editorial:
Genetic Testing: What Problem Are We Trying to Solve?
- PMID: 28820645
- PubMed abstract
- Free Full Text
Letter:
Population-Based Genetic Testing for BRCA1 and BRCA2.
- PMID: 29293388
- PubMed abstract
- Free Full Text
Press: Huge Underuse of Genetic Testing Among Cancer Survivors. (Medscape Oncology)
-
- Cancer Genetic Counseling and Testing in an Era of Rapid Change.
- Hooker GW, Clemens KR, Quillin J, Vogel Postula KJ, Summerour P, Nagy R, Buchanan AH.
- J Genet Couns. 2017 Dec;26(6):1244-1253. doi: 10.1007/s10897-017-0099-2. Epub 2017 Apr 22.
- PMID: 28434142
- PubMed abstract
- Source abstract
-
- Identification and management of familial breast cancer in Austria.
- Singer CF, Tan YY, Rappaport C.
- Horm Mol Biol Clin Investig. 2017 Nov 30;32(2). pii: /j/hmbci.2017.32.issue-2/hmbci-2017-0025/hmbci-2017-0025.xml. doi: 10.1515/hmbci-2017-0025.
- PMID: 29190211
- PubMed abstract
- Source abstract
-
- Testing for BRCA1/2 Mutations.
- Sefton P.
- JAMA. 2017 Nov 28;318(20):2054. doi: 10.1001/jama.2017.17280.
- PMID: 29183078
- PubMed abstract
- Patient page
- Free Full Text
-
- Fast Detection of a BRCA2 Large Genomic Duplication by Next Generation Sequencing as a Single Procedure: A Case Report.
- Nunziato M, Starnone F, Lombardo B, Pensabene M, Condello C, Verdesca F, Carlomagno C, De Placido S, Pastore L, Salvatore F, D'Argenio V.
- Int J Mol Sci. 2017 Nov 22;18(11). pii: E2487. doi: 10.3390/ijms18112487.
- PMID: 29165356
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- Germline BRCA2 mutations detected in pediatric sequencing studies impact parents' evaluation and care.
- Walsh MF, Kennedy J, Harlan M, Kentsis A, Shukla N, Musinsky J, Roberts S, Kung AL, Robson M, Kushner BH, Meyers P, Offit K.
- Cold Spring Harb Mol Case Stud. 2017 Nov 21;3(6). pii: a001925. doi: 10.1101/mcs.a001925. Print 2017 Nov.
- PMID: 28655807
- PubMed abstract
- Source abstract
- Case report
- Free Full Text
-
- What?s Happening to Your DNA Data?: Genetic Testing Services Abound, but Consumers Opting to Use Them Should Be Aware of the Pitfalls.
- Grifantini K.
- IEEE Pulse. 2017 Nov-Dec;8(6):10-14. doi: 10.1109/MPUL.2017.2751121.
- PMID: 29155371
- PubMed abstract
- Source abstract
-
- Screening for familial cancer risk: Focus on breast cancer.
- Rousset-Jablonski C, Gompel A.
- Maturitas. 2017 Nov;105:69-77. doi: 10.1016/j.maturitas.2017.08.004. Epub 2017 Aug 7.
- PMID: 28818315
- PubMed abstract
- Source abstract
-
- Key messages for communicating information about BRCA1 and BRCA2 to women with breast or ovarian cancer: consensus across health professionals and service users.
- Jacobs C, Pichert G, Harris J, Tucker K, Michie S.
- Psychooncology. 2017 Nov;26(11):1818-1824. doi: 10.1002/pon.4379. Epub 2017 Feb 10.
- PMID: 28101941
- PubMed abstract
- Source abstract
-
- Prevalence of deleterious germline variants in risk genes including BRCA1/2 in consecutive ovarian cancer patients (AGO-TR-1).
- Harter P, Hauke J, Heitz F, Reuss A, Kommoss S, Marmé F, Heimbach A, Prieske K, Richters L, Burges A, Neidhardt G, de Gregorio N, El-Balat A, Hilpert F, Meier W, Kimmig R, Kast K, Sehouli J, Baumann K, Jackisch C, Park-Simon TW, Hanker L, Kröber S, Pfisterer J, Gevensleben H, Schnelzer A, Dietrich D, Neunhöffer T, Krockenberger M, Brucker SY, Nürnberg P, Thiele H, Altmüller J, Lamla J, Elser G, du Bois A, Hahnen E, Schmutzler R.
- PLoS One. 2017 Oct 20;12(10):e0186043. doi: 10.1371/journal.pone.0186043. eCollection 2017.
- PMID: 29053726
- PubMed abstract
-
- To Have Or Not To Have Genetic Testing?
- [No author given]
- My Gene Counsel. 2017 Oct 17.
- Blog post
- Free Full Text
-
- Recent Patterns in Genetic Testing for Breast and Ovarian Cancer Risk in the U.S.
- Han X, Jemal A.
- Am J Prev Med. 2017 Oct;53(4):504-507. doi: 10.1016/j.amepre.2017.04.014. Epub 2017 Jun 29.
- PMID: 28669566
- PubMed abstract
- Source abstract
-
- Identification of pathogenic retrotransposon insertions in cancer predisposition genes.
- Qian Y, Mancini-DiNardo D, Judkins T, Cox HC, Brown K, Elias M, Singh N, Daniels C, Holladay J, Coffee B, Bowles KR, Roa BB.
- Cancer Genet. 2017 Oct;216-217:159-169. doi: 10.1016/j.cancergen.2017.08.002. Epub 2017 Aug 24.
- PMID: 29025590
- PubMed abstract
- Source abstract
-
- Impact of germline and somatic BRCA1/2 mutations: Tumor spectrum and detection platforms.
- Wu H, Wu X, Liang Z.
- Gene Ther. 2017 Oct;24(10):601-609. doi: 10.1038/gt.2017.73. Epub 2017 Aug 3.
- PMID: 28771233
- PubMed abstract
- Source abstract
-
- Identification and Characterization of a New BRCA2 Rearrangement in an Italian Family with Hereditary Breast and Ovarian Cancer Syndrome.
- Concolino P, Rizza R, Hackmann K, Minucci A, Scaglione GL, De Bonis M, Costella A, Zuppi C, Schrock E, Capoluongo E.
- Mol Diagn Ther. 2017 Oct;21(5):539-545. doi: 10.1007/s40291-017-0288-6.
- PMID: 28620890
- PubMed abstract
- Source abstract
-
- Referral to cancer genetic counseling: do migrant status and patients’ educational background matter?
- van der Giessen JAM, van Riel E, Velthuizen ME, van Dulmen AM, Ausems MGEM.
- J Community Genet. 2017 Sep 4. doi: 10.1007/s12687-017-0326-4. [Epub ahead of print]
- PMID: 28868568
- PubMed abstract
-
- Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice.
- Solano AR, Cardoso FC, Romano V, Perazzo F, Bas C, Recondo G, Santillan FB, Gonzalez E, Abalo E, Viniegra M, Michel JD, Nuñez LM, Noblia CM, Mc Lean I, Canton ED, Chacon RD, Cortese G, Varela EB, Greco M, Barrientos ML, Avila SA, Vuotto HD, Lorusso A, Podesta EJ, Mando OG.
- Oncotarget. 2016 Jul 24;8(36):60487-60495. doi: 10.18632/oncotarget.10814. eCollection 2017 Sep 1.
- PMID: 28947987
- PubMed abstract
-
- A comparative study of germline BRCA1 and BRCA2 mutation screening methods in use in 20 European clinical diagnostic laboratories.
- Ellison G, Wallace A, Kohlmann A, Patton S.
- Br J Cancer. 2017 Aug 22;117(5):710-716. doi: 10.1038/bjc.2017.223. Epub 2017 Jul 27.
- PMID: 28751759
- PubMed abstract
- Source abstract
-
- [The progress and prospect of application of genetic testing technology-based gene detection technology in the diagnosis and treatment of hereditary cancer].
- He JX, Jiang YF.
- Zhonghua Yu Fang Yi Xue Za Zhi. 2017 Aug 6;51(8):772-776. doi: 10.3760/cma.j.issn.0253-9624.2017.08.022.
- PMID: 28763932
- PubMed abstract
-
- Breast Cancer Genetic Testing Among African Patients With Breast Cancer: Deoxyribonucleic Acid Extraction From Tumor Tissue and International Multidisciplinary Partnerships.
- Amankwaa-Frempong E, Yeboah FA, Nguah SB, Newman LA.
- JAMA Surg. 2017 Aug 1;152(8):800-801. doi: 10.1001/jamasurg.2017.1090.
- PMID: 28514482
- PubMed abstract
- Source abstract
-
- Recurrent large genomic rearrangements in BRCA1 and BRCA2 in an Irish case series.
- McVeigh TP, Cody N, Carroll C, Duff M, Farrell M, Bradley L, Gallagher D, McDevitt T, Green AJ.
- Cancer Genet. 2017 Aug;214-215:1-8. doi: 10.1016/j.cancergen.2017.02.001. Epub 2017 Mar 22.
- PMID: 28595730
- PubMed abstract
- Source abstract
-
- Multi-disciplinary summit on genetics services for women with gynecologic cancers: A Society of Gynecologic Oncology White Paper.
- Randall LM, Pothuri B, Swisher EM, Diaz JP, Buchanan A, Witkop CT, Bethan Powell C, Smith EB, Robson ME, Boyd J, Coleman RL, Lu K.
- Gynecol Oncol. 2017 Aug;146(2):217-224. doi: 10.1016/j.ygyno.2017.06.002. Epub 2017 Jun 7.
- PMID: 28596016
- PubMed abstract
- Source abstract
- Conference report
- Free Full Text
-
- Development of a Streamlined Work Flow for Handling Patients’ Genetic Testing Insurance Authorizations.
- Uhlmann WR, Schwalm K, Raymond VM
- J Genet Couns. 2017 Aug;26(4):657-668. doi: 10.1007/s10897-017-0098-3. Epub 2017 Apr 24.
- PMID: 28439751
- PubMed abstract
- Source abstract
-
- BRCA population screening for predicting breast cancer: for or against?
- Lippi G, Mattiuzzi C, Montagnana M.
- Ann Transl Med. 2017 Jul;5(13):275. doi: 10.21037/atm.2017.06.71.
- PMID: 28758101
- PubMed abstract
-
- Genetic testing and counseling of a recipient after bone marrow transplant from a sibling harboring a germline BRCA1 pathogenic mutation.
- Škerl P, Krajc M, Blatnik A, Novaković S.
- Oncol Rep. 2017 Jul;38(1):279-282. doi: 10.3892/or.2017.5703. Epub 2017 Jun 6.
- PMID: 28586023
- PubMed abstract
- Source abstract
-
- 4 Years Post-Gene Patents: How Has Life Changed In The Genomics World?
- [No author given]
- My Gene Counsel. 2017 Jun 13.
- Blog post
- Free Full Text
-
- The Role of Genetic Testing in Patients With Breast Cancer: A Review.
- Valencia OM, Samuel SE, Viscusi RK, Riall TS, Neumayer LA, Aziz H
- JAMA Surg. 2017 Jun 1;152(6):589-594. doi: 10.1001/jamasurg.2017.0552.
- PMID: 28423155
- PubMed abstract
- Source abstract
-
- Validation of a scale for assessing attitudes towards outcomes of genetic cancer testing among primary care providers and breast specialists.
- Bouhnik AD, N'Diaye K, Evans DG, Harris H, Tibben A, van Asperen C, Schmidtke J, Nippert I, Mancini J, Julian-Reynier C.
- PLoS One. 2017 Jun 1;12(6):e0178447. doi: 10.1371/journal.pone.0178447. eCollection 2017.
- PMID: 28570656
- PubMed abstract
-
- Use of BRCA Mutation Test in the U.S., 2004-2014.
- Guo F, Hirth JM, Lin YL, Richardson G, Levine L, Berenson AB, Kuo YF.
- Am J Prev Med. 2017 Jun;52(6):702-709. doi: 10.1016/j.amepre.2017.01.027. Epub 2017 Mar 22.
- PMID: 28342662
- PubMed abstract
- Source abstract
Press: BRCA Testing Has Skyrocketed, but Misses High-Risk Women. (Medscape)
Letter, Comment:
Increased Use of BRCA Mutation Test in Unaffected Women Over the Period 2004-2014 in the U.S.: Further Evidence of the "Angelina Jolie Effect"?
- PMID: 29054246
- PubMed abstract
- Source abstract
Letter, Reply:
Authors' Response: "Angelina Jolie Effect" on the Shifting Role of BRCA Testing in the U.S.
- PMID: 29054247
- PubMed abstract
- Source abstract
-
- Genomic Testing and Precision Medicine in Cancer Care.
- West HJ, Miller G.
- Medscape. News & Perspective. 2017 May 2.
-
- Optimization of quality assurance to increase clinical utility and cost effectiveness of hereditary cancer testing.
- Smith S, Marino I, Schaller J, Arnell C, Moyes K, Manley S.
- Per Med. 2017 May;14(3):213-220. doi: 10.2217/pme-2016-0091. Epub 2017 Mar 29.
- PMID: 29767585
- PubMed abstract
- Source abstract
-
- Efficacy versus effectiveness of clinical genetic testing criteria for BRCA1 and BRCA2 hereditary mutations in incident breast cancer.
- Nilsson MP, Winter C, Kristoffersson U, Rehn M, Larsson C, Saal LH, Loman N.
- Fam Cancer. 2017 Apr;16(2):187-193. doi: 10.1007/s10689-016-9953-x.
- PMID: 28120249
- PubMed abstract
-
- Orthodox Jewish Thought Leaders' Insights Regarding BRCA Mutations: A Descriptive Study.
- Bressler T, Popp B.
- J Oncol Pract. 2017 Apr;13(4):e303-e309. doi: 10.1200/JOP.2016.015503. Epub 2016 Nov 22.
- PMID: 27875073
- PubMed abstract
- Source abstract
-
- Genetic Cancer Risk Assessment for Breast Cancer in Latin America.
- Chavarri-Guerra Y, Blazer KR, Weitzel JN.
- Rev Invest Clin. 2017 Mar-Apr;69(2):94-102.
- PMID: 28453507
- PubMed abstract
- Source abstract
- Review
- Free Full Text (PDF)
-
- BRCA mutation genetic testing implications in the United States.
- Bayraktar S, Arun B.
- Breast. 2017 Feb;31:224-232. doi: 10.1016/j.breast.2016.11.021. Epub 2016 Dec 6.
- PMID: 27931006
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Retesting BRCA1/BRCA2 mutation negative male breast cancer patients using next generation sequencing technologies.
- Rizzolo P, Silvestri V, Ottini L.
- Breast Cancer Res Treat. 2017 Feb;162(1):199-200. doi: 10.1007/s10549-017-4108-9. Epub 2017 Jan 16.
- PMID: 28091860
- PubMed abstract
- Source abstract
-
- Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab.
- Li H, Feng B, Miron A, Chen X, Beesley J, Bimeh E, Barrowdale D, John EM, Daly MB, Andrulis IL, Buys SS, Kraft P; kConFab investigators, Thorne H, Chenevix-Trench G, Southey MC, Antoniou AC, James PA, Terry MB, Phillips KA, Hopper JL, Mitchell G, Goldgar DE.
- Genet Med. 2017 Jan;19(1):30-35. doi: 10.1038/gim.2016.43. Epub 2016 May 12.
- PMID: 27171545
- PubMed abstract
- Source abstract
-
- Impact of Payer Constraints on Access to Genetic Testing.
- Whitworth P, Beitsch P, Arnell C, Cox HC, Brown K, Kidd J, Lancaster JM.
- J Oncol Pract. 2017 Jan;13(1):e47-e56. doi: 10.1200/JOP.2016.013581. Epub 2016 Oct 23.
- PMID: 28084878
- PubMed abstract
- Source abstract
-
- [Making better use of the clinical geneticist's expertise; treating physician could request a DNA test for most cancer patients].
- Aalfs CM, Westermann AM, van El CG.
- Ned Tijdschr Geneeskd. 2017;161(0):D1525.
- PMID: 28589870
- PubMed abstract
- Source abstract
-
- Breast Cancer Epidemiology, Prevention, and Screening.
- Winters S, Martin C, Murphy D, Shokar NK.
- Prog Mol Biol Transl Sci. 2017;151:1-32. doi: 10.1016/bs.pmbts.2017.07.002. Epub 2017 Oct 10.
- PMID: 29096890
- PubMed abstract
- Source abstract
-
- Genetic Testing After Previous BRCA Testing: A Case Study.
- Ward M.
- Clin J Oncol Nurs. 2016 Dec 1;20(6):660-663.
- PMID: 27857264
- PubMed abstract
- Source abstract
-
- Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.
- D'Andrea E, Marzuillo C, De Vito C, Di Marco M, Pitini E, Vacchio MR, Villari P.
- Genet Med. 2016 Dec;18(12):1171-1180. doi: 10.1038/gim.2016.29. Epub 2016 Apr 14.
- PMID: 27906166
- PubMed abstract
- Source abstract
- Systematic Review
- Free Full Text
-
- The Impact of Angelina Jolie (AJ)'s Story on Genetic Referral and Testing at an Academic Cancer Centre in Canada.
- Raphael J, Verma S, Hewitt P, Eisen A.
- J Genet Couns. 2016 Dec;25(6):1309-1316. Epub 2016 May 26.
- PMID: 27228984
- PubMed abstract
- Source abstract
-
- The effect of referral for genetic counseling on genetic testing and surgical prevention in women at high risk for ovarian cancer: Results from a randomized controlled trial.
- Drescher CW, Beatty JD, Resta R, Andersen MR, Watabayashi K, Thorpe J, Hawley S, Purkey H, Chubak J, Hanson N, Buist DSM, Urban N.
- Cancer. 2016 Nov 15;122(22):3509-3518. doi: 10.1002/cncr.30190. Epub 2016 Jul 22.
- PMID: 27447168
- PubMed abstract
- Source abstract
-
- Utilizing fluorescent life time imaging microscopy technology for identify carriers of BRCA2 mutation.
- Zahavi T, Yahav G, Shimshon Y, Gershanov S, Kaduri L, Sonneblick A, Fixler D, Salmon AY, Salmon-Divon M.
- Biochem Biophys Res Commun. 2016 Nov 4;480(1):36-41. doi: 10.1016/j.bbrc.2016.10.013. Epub 2016 Oct 6.
- PMID: 27721065
- PubMed abstract
- Source abstract
-
- Sensitivity of BRCA1/2 testing in high-risk breast/ovarian/male breast cancer families: little contribution of comprehensive RNA/NGS panel testing.
- Byers H, Wallis Y, van Veen EM, Lalloo F, Reay K, Smith P, Wallace AJ, Bowers N, Newman WG, Evans DG.
- Eur J Hum Genet. 2016 Nov;24(11):1591-1597. doi: 10.1038/ejhg.2016.57. Epub 2016 Jun 8.
- PMID: 27273131
- PubMed abstract
- Source abstract
-
- Use of Cancer Genetics Services in African-American Young Breast Cancer Survivors.
- Jones T, Lockhart JS, Mendelsohn-Victor KE, Duquette D, Northouse LL, Duffy SA, Donley R, Merajver SD, Milliron KJ, Roberts JS, Katapodi MC.
- Am J Prev Med. 2016 Oct;51(4):427-36. doi: 10.1016/j.amepre.2016.03.016. Epub 2016 Apr 23.
- PMID: 27117712
- PubMed abstract
- Source abstract
-
- Want A BRCA Test? Some Insurers Require Genetic Counseling First.
- Michelle Andrews
- NPR. Shots. 2016 Sep 14.
- News
- Free Full Text
-
- Insurers May Insist On Counseling Before Genetic Tests For Breast Cancer.
- Michelle Andrews
- Kaiser Health News. 2016 Sep 13.
- News
- Free Full Text
-
- The biological effects and clinical implications of BRCA mutations: where do we go from here?
- Stoppa-Lyonnet D.
- Eur J Hum Genet. 2016 Sep;24 Suppl 1:S3-9. doi: 10.1038/ejhg.2016.93.
- PMID: 27514841
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- New challenges for BRCA testing: a view from the diagnostic laboratory.
- Wallace AJ.
- Eur J Hum Genet. 2016 Sep;24 Suppl 1:S10-8. doi: 10.1038/ejhg.2016.94.
- PMID: 27514839
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Biology and Management of Patients With Triple-Negative Breast Cancer.
- Sharma P.
- Oncologist. 2016 Sep;21(9):1050-62. doi: 10.1634/theoncologist.2016-0067. Epub 2016 Jul 11.
- PMID: 27401886
- PubMed abstract
- Source abstract
- Review
- Free PMC article
-
- Health Care Segregation, Physician Recommendation, and Racial Disparities in BRCA1/2 Testing Among Women With Breast Cancer.
- McCarthy AM, Bristol M, Domchek SM, Groeneveld PW, Kim Y, Motanya UN, Shea JA, Armstrong K.
- J Clin Oncol. 2016 Aug 1;34(22):2610-8. doi: 10.1200/JCO.2015.66.0019. Epub 2016 May 9.
- PMID: 27161971
- PubMed abstract
- Source abstract
Research News: Racial disparities in BRCA testing: Why? (FORCE)
-
- Health Care Disparities in Hereditary Ovarian Cancer: Are We Reaching the Underserved Population?
- Randall TC, Armstrong K.
- Curr Treat Options Oncol. 2016 Aug;17(8):39. doi: 10.1007/s11864-016-0417-1.
- PMID: 27315065
- PubMed abstract
- Source abstract
-
- Post-mortem testing; germline BRCA1/2 variant detection using archival FFPE non-tumor tissue. A new paradigm in genetic counseling.
- Petersen AH, Aagaard MM, Nielsen HR, Steffensen KD, Waldstrøm M, Bojesen A.
- Eur J Hum Genet. 2016 Aug;24(8):1104-11. doi: 10.1038/ejhg.2015.268. Epub 2016 Jan 6.
- PMID: 26733283
- PubMed abstract
-
- Cambridge start-up expands its genetic test offering.
- Rebecca Burbidge.
- PHG Foundation. 2016 July 15.
- News
- Free Full Text
-
- Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.
- George A, Riddell D, Seal S, Talukdar S, Mahamdallie S, Ruark E, Cloke V, Slade I, Kemp Z, Gore M, Strydom A, Banerjee S, Hanson H, Rahman N.
- Sci Rep. 2016 Jul 13;6:29506. doi: 10.1038/srep29506.
- PMID: 27406733
- PubMed abstract
Comments on NSGC Discussion Forum Cancer SIG
News:
Streamlined genetic testing pathway is developed for women with ovarian cancer.
- PMID: 27418655
- PubMed abstract
- Source abstract
Press: Simplified the Process. (GenomeWeb)
Press: All women with ovarian cancer should be offered genetic testing – so why aren’t they? (Science Blog)
-
- Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
- Staudigl C, Pfeiler G, Hrauda K, Renz R, Berger A, Lichtenschopf R, Singer CF, Tea MM.
- BMC Cancer. 2016 Jul 8;16:436. doi: 10.1186/s12885-016-2472-1.
- PMID: 27391110
- PubMed abstract
-
- Disparities in Cancer Genetic Risk Assessment and Testing.
- Underhill ML, Jones T, Habin K.
- Oncol Nurs Forum. 2016 Jul 1;43(4):519-23. doi: 10.1188/16.ONF.519-523.
- PMID: 27314195
- PubMed abstract
- Source abstract
-
- Methods to identify BRCA testing in claims data.
- Lynch J, Berse B.
- Am J Obstet Gynecol. 2016 Jul;215(1):133-4. doi: 10.1016/j.ajog.2016.03.049. Epub 2016 Apr 12.
- PMID: 27083760
- PubMed abstract
- Source abstract
- Letter
- Free Full Text
Letter / Reply:
Reply.
- PMID: 27060422
- PubMed abstract
- Source abstract
-
- Rates of testing for BRCA mutations in young women are on the rise.
- Barton MK.
- CA Cancer J Clin. 2016 Jul;66(4):269-70. doi: 10.3322/caac.21306. Epub 2016 May 5.
- PMID: 27149306
- PubMed abstract
- Source abstract
- Editorial
- Free Full Text
-
- Evolution of cancer risk assessment and counseling related to psychological, financial and legal implications.
- Snyder C.
- Fam Cancer. 2016 Jul;15(3):493-6. doi: 10.1007/s10689-016-9890-8.
- PMID: 26920353
- PubMed abstract
- Source abstract
-
- Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
- Komenaka IK, Nodora JN, Madlensky L, Winton LM, Heberer MA, Schwab RB, Weitzel JN, Martinez ME.
- J Community Genet. 2016 Jul;7(3):177-83. doi: 10.1007/s12687-015-0257-x. Epub 2015 Dec 21.
- PMID: 26690931
- PubMed abstract
- Source abstract
-
- Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).
- Choi MC, Lim MC, Suh DH, Song YJ, Kim TJ, Chang SJ, Kim JW; Korean Society of Gynecologic Oncology.
- J Gynecol Oncol. 2016 Jul;27(4):e36. doi: 10.3802/jgo.2016.27.e36. Epub 2016 Mar 30.
- PMID: 27102245
- PubMed abstract
-
- Genetic testing for hereditary breast cancer in Asia-moving forward.
- Kwong A.
- Chin Clin Oncol. 2016 Jun;5(3):47. doi: 10.21037/cco.2016.05.11.
- PMID: 27265304
- PubMed abstract
- Source abstract
- Editorial / Commentary
- Free Full Text
-
- Impact of Clinical Genetics Attendance at a Gynecologic Oncology Tumor Board on Referrals for Genetic Counseling and BRCA Mutation Testing.
- Cohen PA, Nichols CB, Schofield L, Van Der Werf S, Pachter N.
- Int J Gynecol Cancer. 2016 Jun;26(5):892-7. doi: 10.1097/IGC.0000000000000689.
- PMID: 27051053
- PubMed abstract
- Source abstract
-
- Testing for Hereditary Predisposition in Patients with Gynecologic Cancers, Quo Vadis?
- Mitchell G, Schrader KA.
- Surg Pathol Clin. 2016 Jun;9(2):301-6. doi: 10.1016/j.path.2016.01.009. Epub 2016 Apr 11.
- PMID: 27241110
- PubMed abstract
- Source abstract
-
- Oncogenetics service and the Brazilian public health system: the experience of a reference Cancer Hospital.
- Palmero EI, Galvão HC, Fernandes GC, Paula AE, Oliveira JC, Souza CP, Andrade CE, Romagnolo LG, Volc S, C Neto M, Sabato C, Grasel R, Mauad E, Reis RM, Michelli RA.
- Genet Mol Biol. 2016 May 13;39(2):168-177. doi: 10.1590/1678-4685-GMB-2014-0364.
-
- Discussion: Should We Test Minors For Hereditary Cancer Syndromes?
- [No author given]
- My Gene Counsel. 2016 May 2.
- Blog post
- Free Full Text
-
- Podcast: Don't Allow The Wrong Genetic Test To Be Ordered For Your Family.
- Ellen T. Matloff.
- My Gene Counsel. 2016 Apr 26.
- Blog post, Podcast
- Free Full Text
-
- More People Seek Genetic Testing, But There Aren't Enough Counselors.
- Todd Bookman.
- NPR. Morning Edition. 2016 Apr 18.
- News, Audio/Transcript
- Free Full Text
-
- Which BRCA genetic testing programs are ready for implementation in health care? A systematic review of economic evaluations.
- Elvira D’Andrea, Carolina Marzuillo, Corrado De Vito, Marco Di Marco, Erica Pitini, Maria Rosaria Vacchio, Paolo Villari.
- Genet Med. 2016 Apr 14.
- Review
- Free Full Text
-
- NCCN Adds New Gene Mutations to Consider in Women's Cancers.
- Fran Lowry.
- Medscape Medical News. Oncology. National Comprehensive Cancer Network (NCCN) 21st Annual Conference. 2016 Apr 4.
- Conference report
- Free Full Text
-
- Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond.
- Hall MJ, Obeid EI, Schwartz , Mantia-Smaldone G, Forman AD, Daly MB.
- Gynecol Oncol. 2016 Mar;140(3):565-74. doi: 10.1016/j.ygyno.2016.01.019. Epub 2016 Jan 23.
- PMID: 26812021
- PubMed abstract
- Source abstract
-
- Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.
- Daly MB, Pilarski R, Axilbund JE, Berry M, Buys SS, Crawford B, Farmer M, Friedman S, Garber JE, Khan S, Klein C, Kohlmann W, Kurian A, Litton JK, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Rana H, Reiser G, Robson ME, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wick MJ, Wiesner GL, Dwyer M, Kumar R, Darlow S.
- J Natl Compr Canc Netw. 2016 Feb;14(2):153-62.
- PMID: 26850485
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
-
- Breast Cancer Genetic Counseling: A Surgeon's Perspective.
- Agnese DM, Pollock RE.
- Front Surg. 2016 Jan 28;3:4. doi: 10.3389/fsurg.2016.00004. eCollection 2016.
- PMID: 26858951
- PubMed abstract
- Review
- Free PMC article
- Free Full Text
-
- Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing.
- Modell SM, Greendale K, Citrin T, Kardia SL.
- Healthcare (Basel). 2016 Jan 27;4(1). pii: E14. doi: 10.3390/healthcare4010014.
- PMID: 27417602
- PubMed abstract
- Source abstract
-
- Sweeping Up after the Kardashians: What We Wish had been Covered in Their Genetic Testing Episode.
- [No author given]
- My Gene Counsel. 2016 Jan 22.
- Blog post
- Free Full Text
-
- Genetic screening for gynecological cancer: where are we heading?
- Manchanda R, Jacobs I.
- Future Oncol. 2016 Jan;12(2):207-20. doi: 10.2217/fon.15.278. Epub 2015 Dec 7.
- PMID: 26638726
- PubMed abstract
- Source abstract
-
- Current Status of the Management of Hereditary Breast and Ovarian Cancer in Asia: First Report by the Asian BRCA Consortium.
- Nakamura S, Kwong A, Kim SW, Iau P, Patmasiriwat P, Dofitas R, Aryandono T, Hu Z, Huang CS, Ginsburg O, Rashid MU, Sarin R, Teo SH.
- Public Health Genomics. [2016 Jan;]19(1):53-60. doi: 10.1159/000441714. Epub 2015 Nov 18.
- PMID: 26575363
- PubMed abstract
- Source abstract
-
- Refining Breast Cancer Risk Stratification: Additional Genes, Additional Information.
- Kurian AW, Antoniou AC, Domchek SM.
- Am Soc Clin Oncol Educ Book. 2016;35:44-56. doi: 10.14694/EDBK_158817.
- PMID: 27249685
- PubMed abstract
- Source abstract
- Review
- Free Full Text
-
- Some Legal Issues Regarding the Patenting of Human Genetic Materials.
- MacFarlane P, Kontoleon B.
- J Law Med. 2016;24(1):181-202.
- PMID: 30136781
- PubMed abstract
- ToC
-
- Some Legal Issues Regarding the Patenting of Human Genetic Materials.
- MacFarlane P, Kontoleon B.
- J Law Med. 2016;24(1):181-202.
- PMID: 30136782
- PubMed abstract
- ToC
-
- Diagnosis and Management of Hereditary Pancreatic Cancer.
- Humphris JL, Biankin AV.
- Recent Results Cancer Res. 2016;205:61-83. doi: 10.1007/978-3-319-29998-3_5.
- PMID: 27075349
- PubMed abstract
-
- [CHEK2-associated hereditary breast cancer].
- Bessonov AA, Iyevleva AG, Imyanitov EN, Sokolenko AP.
- Vopr Onkol. 2016;62(6):753-757.
- PMID: 30695561
- PubMed abstract
-
- The Science -- Or Lack Of It -- Behind Genetic Tests Offered In The Workplace.
- David Shaywitz.
- Forbes. 2015 Dec 18.
- Press article
- Free Full Text
-
- Genetic Testing May Be Coming to Your Office.
- Rachel Emma Silverman.
- The Wall Street Journal. Business. 2015 Dec 15.
- Press article
- Free Full Text
-
- Discussing Genetic Testing With Patients With Breast Cancer in Developing Countries: Should We Be Judicious?
- Hafeez Bhatti AB.
- J Clin Oncol. 2015 Dec 10;33(35):4232-3. doi: 10.1200/JCO.2015.63.3974. Epub 2015 Sep 14.
- PMID: 26371136
- PubMed abstract
- Comment, Letter
- Free Full Text
Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
- PMID: 25847940
- PubMed abstract
- Source abstract
Reply / Letter
Reply to S.M. Sorscher and A.B. Hafeez Bhatti.
- PMID: 26371137
- PubMed abstract
- Free full text
-
- Genetic Testing for BRCA Mutations Today and Tomorrow-About the ABOUT Study.
- Narod S.
- JAMA Oncol. 2015 Dec 1;1(9):1225-1226. doi: 10.1001/jamaoncol.2015.3269.
- PMID: 26426337
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: Dr. Narod's commentary on pre-test genetic counseling
Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
- PMID: 26426480
- PubMed abstract
- Free full text
-
- Utilization and Outcomes of BRCA Genetic Testing and Counseling in a National Commercially Insured Population: The ABOUT Study.
- Armstrong J, Toscano M, Kotchko N, Friedman S, Schwartz MD, Virgo KS, Lynch K, Andrews JE, Aguado Loi CX, Bauer JE, Casares C, Bourquardez Clark E, Kondoff MR, Molina AD, Abdollahian M, Walker G, Sutphen R.
- JAMA Oncol. 2015 Dec 1;1(9):1251-1260. doi: 10.1001/jamaoncol.2015.3048.
- PMID: 26426480
- PubMed abstract
Blog post: Rates of Genetic Testing on the Rise While Utilization of Genetic Counseling Plummets (My Gene Counsel)
Press: Most Women Get No Counseling After BRCA Testing (Medscape Oncology)
Press: Study of Aetna-Insured Finds Lack of Pre-BRCA Test Counseling Despite Guidelines (GenomeWeb)
Press: BRCA Testing, Genetic Counseling Utilization in the Community Setting (OncoTherapy Network)
Press: Too Few Women Get Counseling Before Breast Cancer Gene Test: Study (MedlinePlus)
Press: Too Few Get Counseling Before BRCA Gene Test (WEbMD / HealthDay News)
-
- Beyond BRCA: Testing negative and living in the 'gray zone' for cancer risk.
- [No author given]
- My Gene Counsel. 2015 Dec 1.
- Blog post
- Free Full Text
-
- Passage of Medicare mandate fails to shorten time to BRCA testing in ovarian cancer patients.
- Olga T. Filippova, Paul J. Feustel, Lisa M. Armao, Joyce N. Barlin, Timothy J. McElrath, Patrick F. Timmins, Daniel C. Kredentser, Heidi E. Godoy.
- Gynecologic Oncology. 2015 Dec;139(3):594. 2015 NEAGO ABSTRACTS. doi: 10.1016/j.ygyno.2015.09.053.
-
- Testing times for BRCA gene carriers.
- Carlisle D.
- Nurs Stand. 2015 Nov 11;30(11):17-9. doi: 10.7748/ns.30.11.17.s21.
- PMID: 26554972
- PubMed abstract
- Source abstract
-
- Ovarian cancer study opens door to personalised medicine.
- Rebecca Burbidge.
- PHG Foundation. 2015 Nov 11.
- News
- Free Full Text
-
- Addressing health disparities in Hispanic breast cancer: accurate and inexpensive sequencing of BRCA1 and BRCA2.
- Dean M, Boland J, Yeager M, Im KM, Garland L, Rodriguez-Herrera M, Perez M, Mitchell J, Roberson D, Jones K, Lee HJ, Eggebeen R, Sawitzke J, Bass S, Zhang X, Robles V, Hollis C, Barajas C, Rath E, Arentz C, Figueroa JA, Nguyen DD, Nahleh Z.
- Gigascience. 2015 Nov 4;4:50. doi: 10.1186/s13742-015-0088-z. eCollection 2015.
- PMID: 26543556
- PubMed abstract
-
- Getting Tested For The 'Breast Cancer Genes'
- Justin Lorentz
- Huffington Post Canada, Living, 2015 Oct 30
- Press article, Blog post
- Free Full Text
-
- UC Launches Framingham-Like Study to Inform Personalized Breast Cancer Screening Guidelines.
- Ray T.
- GenomeWeb. 2015 Oct 26.
-
- The Insider’s Guide on Genetic Testing for Breast Cancer.
- [No author given]
- My Gene Counsel. 2015 Oct 6.
- Blog post
- Free Full Text
-
- Breast Cancer Genetic Testing: More Than a Medical Management Tool.
- Schroeder D, Conroy SA.
- Clin J Oncol Nurs. 2015 Oct 1;19(5):603-7. doi: 10.1188/15.CJON.603-607.
- PMID: 26414578
- PubMed abstract
- Source abstract
-
- Utility of genetic testing for breast cancer risk.
- [No author given]
- The Jackson Laboratory. 2015 Oct.
-
- Alison's Story-A Cautionary Tale in the Age of Genomic Medicine.
- Burn J.
- Surg Oncol Clin N Am. 2015 Oct;24(4):635-637. doi: 10.1016/j.soc.2015.06.010. Epub 2015 Aug 14.
- PMID: 26363533
- PubMed abstract
- Source abstract
-
- Color Genomics Launches Benefits Program for Breast, Ovarian Cancer Risk Testing.
- [No author given]
- Clinical OMICs. 2015 Sep 30.
- News
- Free Full Text
-
- Your Checklist For Ovarian Cancer Genetic Counseling.
- [No author given].
- My Gene Counsel. 2015 Sep 24.
- Blog post
- Free Full Text
-
- Who Should Be Concerned About Hereditary Cancer?
- [No author given]
- My Gene Counsel. 2015 Sep 22.
- Blog post
- Free Full Text
-
- "The BRCA Responder" on Genetic Testing, Family Histories, and Why Counseling Is Key.
- Kelly Johnson.
- Oncology Nursing News. 2015 Aug 31.
- Press article
- Free Full Text
-
- Genetic Testing Can Lead to Insights — Or Uncertainty.
- Lauren M. Green.
- Cure. 2015 Aug 13.
- Press article
- Free Full Text
-
- Discrepancies between ESMO and NCCN breast cancer guidelines: An appraisal.
- Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C, Zografos GC, Dimopoulos MA, Azim HA Jr.
- Breast. 2015 Aug;24(4):513-23. doi: 10.1016/j.breast.2015.02.031. Epub 2015 Mar 25.
- PMID: 25818651
- PubMed abstract
- Source abstract
-
- Video: Genetic Testing for only $249?
- [No author given]
- My Gene Counsel. 2015 Jul 21.
- Blog post, Video
- Free Full Text
-
- BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.
- Zhen DB, Rabe KG, Gallinger S, Syngal S, Schwartz AG, Goggins MG, Hruban RH, Cote ML, McWilliams RR, Roberts NJ, Cannon-Albright LA, Li D, Moyes K, Wenstrup RJ, Hartman AR, Seminara D, Klein AP, Petersen GM.
- Genet Med. 2015 Jul 2;17(7):569-577. doi: 10.1038/gim.2014.153. Epub 2014 Nov 20.
- PMID: 25356972
- PubMed abstract
- Source abstract
-
- Testing helps fight ovarian, breast cancers—but not everyone agrees on how to do it.
- Maria Delaney.
- Ars Technica. 2015 Jul 1.
- Press article
- Free Full Text
-
- Podcast: Real Men Get Genetic Counseling.
- [No author given]
- My Gene Counsel. 2015 Jun 30.
- Blog post, Podcast
- Free Full Text
-
- Genetics and Cancer Risk: More options, more tests, more prevention, more survivors.
- Billie J. Marek.
- The Monitor. 2015 Jun 25.
- Press article
- Free Full Text
-
- Breast Cancer Risk Gene Discovery: Opportunities and Challenges.
- Fabienne Lesueur.
- Current Genetic Medicine Reports 3(2):8-91. 2015 Jun.
-
- Committee opinion no. 634: Hereditary cancer syndromes and risk assessment.
- [No authors listed]
- Obstet Gynecol. 2015 Jun;125(6):1538-43. doi: 10.1097/01.AOG.0000466373.71146.51.
- PMID: 26000542
- PubMed abstract
Press: ACOG Issues Guidelines for Hereditary Cancer Screening. (Medscape Oncology)
-
- How Genetic Tests Can Reveal a Hidden Family History of Cancer.
- [No author given]
- NBC Nightly News. 2015 May 20.
- Press article, Video
- Free Full Text
-
- Two Women, Two Results: The Agonizing Wait for Cancer Gene Tests.
- [No author given]
- NBC Nightly News. 2015 May 19.
- Press article, Video
- Free Full Text
-
- A WILD RIDE: A Genetic Counselor Undergoes Genetic Testing.
- Caroline Lieber.
- NSGC Blog. 2015 May 13.
- Blog post
- Free Full Text
-
- Concerns about cancer risk and experiences with genetic testing in a diverse population of patients with breast cancer.
- Jagsi R, Griffith KA, Kurian AW, Morrow M, Hamilton AS, Graff JJ, Katz SJ, Hawley ST.
- J Clin Oncol. 2015 May 10;33(14):1584-91. doi: 10.1200/JCO.2014.58.5885. Epub 2015 Apr 6.
- PMID: 25847940
- PubMed abstract
- Source abstract
Comment / Letter:
Discussing the Implications of Genetic Testing With Patients.
- PMID: 26371142
- PubMed abstract
- Free article
Comment / Letter:
Reply to S.M. Sorscher and A.B. Hafeez Bhatti.
- PMID: 26371137
- PubMed abstract
- Free article
Comment / Letter:
Discussing Genetic Testing With Patients With Breast Cancer in Developing Countries: Should We Be Judicious?
- PMID: 26371136
- PubMed abstract
- Free article
Press: Women With Breast Cancer Concerned About Genetic Risk. (Medscape Oncology)
-
- Factors associated with genetic counseling and BRCA testing in a population-based sample of young Black women with breast cancer.
- Cragun D, Bonner D, Kim J, Akbari MR, Narod SA, Gomez-Fuego A, Garcia JD, Vadaparampil ST, Pal T.
- Breast Cancer Res Treat. 2015 May;151(1):169-76. doi: 10.1007/s10549-015-3374-7. Epub 2015 Apr 14.
- PMID: 25868867
- PubMed abstract
- Source abstract
-
- Pre-test genetic counseling services for hereditary breast and ovarian cancer delivered by non-genetics professionals in the state of Florida.
- Vadaparampil ST, Scherr CL, Cragun D, Malo TL, Pal T.
- Clin Genet. 2015 May;87(5):473-7. doi: 10.1111/cge.12405. Epub 2014 May 9.
- PMID: 24735105
- PubMed abstract
- Source abstract
Letter:
Response to Cragun et al.
- PMID: 25256678
- PubMed abstract
- Source abstract
Letter:
Response to Cragun et al.
- PMID: 25381838
- PubMed abstract
- Source abstract
-
- Great Expectorations – A NextGenetic Counseling Model?
- Robert Resta.
- The DNA Exchange. 2015 Apr 27.
- Blog post
- Free Full Text
-
- Affordable access to a new genetic test for cancer.
- Andrea.
- Brave Bosom. 2015 Apr 21.
- Blog post
- Free Full Text
-
- New Genetic Tests for Breast Cancer Hold Promise.
- Andrew Pollack.
- NY Times, Business Day. 2015 Apr 21.
- Press article
- Free Full Text
Press: Startup Pledges To Cut Cost Of Breast Cancer Genetic Testing From $4000 To $249. (Forbes)
-
- Screening Tests For Breast Cancer Genes Just Got Cheaper.
- [No author given]
- NPR. All Things Considered. 2015 Apr 21.
- Press article, Audio
- Free Full Text
-
- Learning from Angelina Jolie's genetic testing for our own health.
- Elizabeth Cohen.
- CNN, 2015 Mar 25.
- Press article
- Free Full Text
-
- Personalized assessment and management of women at risk for breast cancer in North America.
- Pruthi S, Heisey R, Bevers T.
- Womens Health (Lond Engl). 2015 Mar;11(2):213-23; quiz 223-4. doi: 10.2217/whe.14.79.
- PMID: 25776295
- PubMed abstract
- Source abstract
- Review
- Free Full Text (PDF)
-
- Prevalence and correlates of receiving and sharing high-penetrance cancer genetic test results: findings from the Health Information National Trends Survey.
- Taber JM, Chang CQ, Lam TK, Gillanders EM, Hamilton JG, Schully SD.
- Public Health Genomics. [2015 Feb;]18(2):67-77. doi: 10.1159/000368745.
- PMID: 25427996
- PubMed abstract
- Source abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women.
- Lee K, Rossi C.
- Am Fam Physician. 2015 Jan 15;91(2):119-120.
- PMID: 25591214
- PubMed abstract
- Case report
- Free Full Text
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: Recommendation Statement.
- [No authors listed]
- Am Fam Physician. 2015 Jan 15;91(2):Online.
- PMID: 25591222
- PubMed abstract
-
- Yes, breast surgeons may provide breast cancer genetic assessment and testing.
- Kaufman CS.
- Ann Surg Oncol. 2015 Jan;22(1):1-3. doi: 10.1245/s10434-014-4124-5. Epub 2014 Oct 8.
- PMID: 25294019
- PubMed abstract
- Editorial / Commentary
- Free Full Text
Comment / Editorial:
Can breast surgeons provide breast cancer genetic testing? An American Society of Breast Surgeons survey.
- PMID: 24756810
- PubMed abstract
- Source abstract
-
- Differences in BRCA counseling and testing practices based on ordering provider type.
- Cragun D, Camperlengo L, Robinson E, Caldwell M, Kim J, Phelan C, Monteiro AN, Vadaparampil ST, Sellers TA, Pal T.
- Genet Med. 2015 Jan;17(1):51-57. doi: 10.1038/gim.2014.75. Epub 2014 Jun 12.
- PMID: 24922460
- PubMed abstract
- Source abstract
Press: Involving a genetic health care professional may improve quality, reduce unnecessary testing. (Science Daily)
Press: Survey: Genetic Counseling Leads Some Patients to Cheaper BRCA Tests. (GenomeWeb)
Blog post: Survey: Genetic Counseling Leads Some Patients to Cheaper BRCA Tests. (Yale Cancer Genetic Counseling)
-
- A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
- Hampel H, Bennett RL, Buchanan A, Pearlman R, Wiesner GL.
- Genet Med. 2015 Jan;17(1):70-87. doi: 10.1038/gim.2014.147. Epub 2014 Nov 13.
- PMID: 25394175
- PubMed abstract
- Source abstract
Addendum:
Addendum: A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
-
- Hereditary breast cancer syndromes and genetic testing.
- Rich TA, Woodson AH, Litton J, Arun B.
- J Surg Oncol. 2015 Jan;111(1):66-80. doi: 10.1002/jso.23791. Epub 2014 Nov 7.
- PMID: 25381882
- PubMed abstract
- Source abstract
-
- Efficacy of a web-based intelligent tutoring system for communicating genetic risk of breast cancer: a fuzzy-trace theory approach.
- Wolfe CR, Reyna VF, Widmer CL, Cedillos EM, Fisher CR, Brust-Renck PG, Weil AM.
- Med Decis Making. 2015 Jan;35(1):46-59. doi: 10.1177/0272989X14535983. Epub 2014 May 14.
- PMID: 24829276
- PubMed abstract
- Source abstract
-
- The changing landscape of genetic testing for hereditary breast and ovarian cancer.
- Bellcross CA.
- Curr Probl Cancer. 2014 Nov-Dec;38(6):209-15. doi: 10.1016/j.currproblcancer.2014.10.001. Epub 2014 Oct 30.
- PMID: 25497408
- PubMed abstract
- Source abstract
-
- Identifying hereditary cancer: genetic counseling and cancer risk assessment.
- Lewis KM.
- Curr Probl Cancer. 2014 Nov-Dec;38(6):216-25. doi: 10.1016/j.currproblcancer.2014.10.002. Epub 2014 Oct 29.
- PMID: 25432528
- PubMed abstract
- Source abstract
-
- Hereditary breast and ovarian cancer syndrome: Considering the complexities.
- Senter L.
- Curr Probl Cancer. 2014 Nov-Dec;38(6):226-34. doi: 10.1016/j.currproblcancer.2014.10.003. Epub 2014 Oct 31.
- PMID: 25497409
- PubMed abstract
- Source abstract
-
- Current Guidance for Brca Mutation Testing in Ovarian Cancer Patients.
- Ehlken B, Driedger J, Hofmann-Xu L, Paulus G, Berger K, de Moor C, Schroeder C, Clune J, Tyczynski J.
- Value Health. 2014 Nov;17(7):A663. doi: 10.1016/j.jval.2014.08.2439. Epub 2014 Oct 26.
- PMID: 27202417
- PubMed abstract
- Source abstract
-
- Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative.
- Brannon Traxler L, Martin ML, Kerber AS, Bellcross CA, Crane BE, Green V, Matthews R, Paris NM, Gabram SG.
- Ann Surg Oncol. 2014 Oct;21(10):3342-7. doi: 10.1245/s10434-014-3921-1. Epub 2014 Jul 22.
- PMID: 25047474
- PubMed abstract
- Source abstract
Comments from NSGC Discussion Forum Cancer SIG
Subject: Article Request
-
- Breast cancer risk counseling: a teachable moment?
- Daly M.
- J Natl Compr Canc Netw. 2014 Oct;12(10):1361-2.
- PMID: 25313176
- PubMed abstract
- Source abstract
Comments on NSGC Discussion Forum Cancer SIG
Subject: Article request
-
- Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy.
- Hanoch Y, Miron-Shatz T, Rolison JJ, Ozanne E.
- Psychooncology. 2014 Oct;23(10):1142-8. doi: 10.1002/pon.3537. Epub 2014 Apr 14.
- PMID: 24733657
- PubMed abstract
- Source abstract
-
- The Angelina Jolie effect: how high celebrity profile can have a major impact on provision of cancer related services.
- Evans DG, Barwell J, Eccles DM, Collins A, Izatt L, Jacobs C, Donaldson A, Brady AF, Cuthbert A, Harrison R, Thomas S, Howell A; The FH02 Study Group; RGC teams, Miedzybrodzka Z, Murray A; The FH02 Study Group; RGC Teams.
- Breast Cancer Res. 2014 Sep 19;16(5):442. doi: 10.1186/s13058-014-0442-6.
- PMID: 25510853
- PubMed abstract
Comment, Letter:
Longer term effects of the Angelina Jolie effect: increased risk-reducing mastectomy rates in BRCA carriers and other high-risk women.
- PMID: 26603733
- PubMed abstract
- Free Full Text
-
- Genetic Testing For BRCA Is A Personal Decision.
- Elaine Schattner.
- Forbes. 2014 Sep 11.
- Press article
- Free Full Text
-
- 'Angelina Jolie Effect': BRCA Testing Doubles.
- Zosia Chustecka.
- Medscape Medical News. Conference News. from the 2014 Breast Cancer Symposium. 2014 Sep 3.
- News
- Free Full Text
Conference abstract: The impact of Angelina Jolie's (AJ) story on genetic referral and testing at an academic cancer centre. (ASCO University. Meeting Library.)
-
- Angelina Jolie’s Surgery May Have Doubled Genetic Testing Rates at One Clinic.
- Alexandra Sifferlin.
- Time. 2014 Sep 2.
- Press article
- Free Full Text
Conference abstract: The impact of Angelina Jolie's (AJ) story on genetic referral and testing at an academic cancer centre. (ASCO University. Meeting Library.)
Press article:
The Angelina effect.
- PMID: 24044164
- PubMed abstract
- Source abstract
-
- Genetic/Familial high-risk assessment: breast and ovarian, version 1.2014.
- Daly MB, Pilarski R, Axilbund JE, Buys SS, Crawford B, Friedman S, Garber JE, Horton C, Kaklamani V, Klein C, Kohlmann W, Kurian A, Litton J, Madlensky L, Marcom PK, Merajver SD, Offit K, Pal T, Pasche B, Reiser G, Shannon KM, Swisher E, Voian NC, Weitzel JN, Whelan A, Wiesner GL, Dwyer MA, Kumar R.
- J Natl Compr Canc Netw. 2014 Sep;12(9):1326-38.
- PMID: 25190698
- PubMed abstract
- Source abstract
-
- Advanced tools for BRCA1/2 mutational screening: comparison between two methods for large genomic rearrangements (LGRs) detection.
- Concolino P, Mello E, Minucci A, Santonocito C, Scambia G, Giardina B, Capoluongo E.
- Clin Chem Lab Med. 2014 Aug;52(8):1119-27. doi: 10.1515/cclm-2013-1114.
- PMID: 24670361
- PubMed abstract
- Source abstract
-
- Genetic testing and familial implications in breast-ovarian cancer families.
- Oosterwijk JC, de Vries J, Mourits MJ, de Bock GH.
- Maturitas. 2014 Aug;78(4):252-257. doi: 10.1016/j.maturitas.2014.05.002. Epub 2014 May 9.
- PMID: 24894332
- PubMed abstract
- Source abstract
-
- Medical genetic counseling for breast cancer in primary care: a synthesis of major determinants of physicians' practices in primary care settings.
- Jbilou J, Halilem N, Blouin-Bougie J, Amara N, Landry R, Simard J.
- Public Health Genomics. [2014 Aug;]17(4):190-208. doi: 10.1159/000362358. Epub 2014 Jul 3.
- PMID: 24993835
- PubMed abstract
- Review
- Free Full Text
-
- From the set-up of a screening program of breast cancer patients to the identification of the first BRCA mutation in the DR Congo.
- Luyeye Mvila G, Postema S, Marchal G, Van Limbergen E, Verdonck F, Matthijs G, Devriendt K, Michils G, Van Ongeval C.
- BMC Public Health. 2014 Jul 28;14:759. doi: 10.1186/1471-2458-14-759.
- PMID: 25070656
- PubMed abstract
-
- The Role of Testing for BRCA1 and BRCA2 Mutations in Cancer Prevention.
- McCarthy AM, Armstrong K.
- JAMA Intern Med. 2014 Jul 1;174(7):1023-4. doi: 10.1001/jamainternmed.2014.1322.
- PMID: 24841841
- PubMed abstract
- Source abstract
- Editorial / Commentary
- Free PMC article
-
- Survey Finds More Inquiries to Genetic Counselors, Including From the “Worried-Well”.
- Christina Izzo.
- Oncology Nursing News. 2014 Jun 9.
- News
- Free Full Text
-
- More breast cancer patients prefer BRCA-mutation testing without prior face-to-face genetic counseling.
- Sie AS, van Zelst-Stams WA, Spruijt L, Mensenkamp AR, Ligtenberg MJ, Brunner HG, Prins JB, Hoogerbrugge N.
- Fam Cancer. 2014 Jun;13(2):143-51. doi: 10.1007/s10689-013-9686-z.
- PMID: 24068317
- PubMed abstract
- Source abstract
-
- Angelina Jolie Effect: One Year Later.
- Joy Larsen Haidle.
- NSGC Blog. 2014 May 14.
- Blog post
- Free Full Text
-
- Long-term satisfaction and quality of life following risk reducing surgery in BRCA1/2 mutation carriers.
- Hooker GW, King L, Vanhusen L, Graves K, Peshkin BN, Isaacs C, Taylor KL, Poggi E, Schwartz MD.
- Hered Cancer Clin Pract. 2014 Apr 2;12(1):9. doi: 10.1186/1897-4287-12-9.
- PMID: 24690515
- PubMed abstract
-
- Determinants of genetic counseling uptake and its impact on breast cancer outcome: a population-based study.
- Ayme A, Viassolo V, Rapiti E, Fioretta G, Schubert H, Bouchardy C, Chappuis PO, Benhamou S.
- Breast Cancer Res Treat. 2014 Apr;144(2):379-89. doi: 10.1007/s10549-014-2864-3. Epub 2014 Feb 12.
- PMID: 24519389
- PubMed abstract
- Source abstract
-
- Changes in specialists' perspectives on cancer genetic testing, prophylactic surgery and insurance discrimination: then and now.
- Matloff ET, Bonadies DC, Moyer A, Brierley KL.
- J Genet Couns. 2014 Apr;23(2):164-71. doi: 10.1007/s10897-013-9625-z. Epub 2013 Jul 13.
- PMID: 23852268
- PubMed abstract
- Source abstract
Press: What’s Ahead for BRCA Genetic Testing and Counseling? (OncLive)
-
- Experiences of predictive testing in young people at risk of Huntington's disease, familial cardiomyopathy or hereditary breast and ovarian cancer.
- Macleod R, Beach A, Henriques S, Knopp J, Nelson K, Kerzin-Storrar L.
- Eur J Hum Genet. 2014 Mar;22(3):396-401. doi: 10.1038/ejhg.2013.143. Epub 2013 Jul 17.
- PMID: 23860040
- PubMed abstract
- Source abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- Nelson HD, Pappas M, Zakher B, Mitchell JP, Okinaka-Hu L, Fu R.
- Ann Intern Med. 2014 Feb 18;160(4):255-66.
- PMID: 24366442
- PubMed abstract
- Review
- Free Full Text
Quality-assessed Review: Database of Abstracts of Reviews of Effects (DARE) (PubMed Health)
-
- Assessing the Genetic Risk for BRCA-Related Breast or Ovarian Cancer in Women: Recommendations From the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4). doi: 10.7326/P14-9008.
- PMID: 24366402
- PubMed abstract
- Summary for Patients
- Free Full Text
Systematic Review:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation.
- PMID: 24366442
- PubMed abstract
-
- Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- Moyer VA; U.S. Preventive Services Task Force.
- Ann Intern Med. 2014 Feb 18;160(4):271-81.
- PMID: 24366376
- PubMed abstract
- Practice Guideline
- Free Full Text
Patient Education Handout:
Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- PMID: 25006622
- PubMed abstract
-
- Summaries for patients. Assessing the genetic risk for BRCA-related breast or ovarian cancer in women: recommendations from the U.S. Preventive Services Task Force.
- [No authors listed]
- Ann Intern Med. 2014 Feb 18;160(4):I-16.
- PMID: 25006622
- PubMed abstract
- Summary for Patients
- Free Full Text
Practice Guideline:
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement.
- PMID: 24366376
- PubMed abstract
-
- After Angelina and the Supreme Court Decision, where do we go from here? BRCA gene testing in Rhode Island's Portuguese population.
- Benson C, Stobie L, Shur N, Yuan Z, Teixeira MR, Chung M.
- Am J Med Genet A. 2014 Feb;164(2):557-8. doi: 10.1002/ajmg.a.36254. Epub 2013 Dec 5.
- PMID: 24311519
- PubMed abstract
- Source abstract
-
- High-risk women should have BRCA testing.
- [No authors listed]
- Cancer Discov. 2014 Feb;4(2):139. doi: 10.1158/2159-8290.CD-NB2014-003. Epub 2014 Jan 16.
- PMID: 24501290
- PubMed abstract
- Source abstract
-
- Molecular testing in breast cancer.
- Paoletti C, Hayes DF.
- Annu Rev Med. 2014 Jan 14;65:95-110. doi: 10.1146/annurev-med-070912-143853.
- PMID: 24422569
- PubMed abstract
- Source abstract
-
- U.S. Preventive Services Task Force Finds Benefit in Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer for Small Group of High-Risk Women.
- [No author given]
- Yale Cancer Genetic Counseling. 2014 Jan 2.
- News, Blog post
- Free Full Text
-
- Modes of delivery of genetic testing services and the uptake of cancer risk management strategies in BRCA1 and BRCA2 carriers.
- Pal T, Lee JH, Besharat A, Thompson Z, Monteiro A, Phelan C, Lancaster J, Metcalfe K, Sellers T, Vadaparampil S, Narod S.
- Clin Genet. 2014 Jan;85(1):49-53. doi: 10.1111/cge.12130. Epub 2013 Mar 21.
- PMID: 23438721
- PubMed abstract
- Source abstract
-
- Systematic review of educational tools used during the BRCA1/2 genetic testing process.
- Dorval M, Bouchard K, Chiquette J.
- Per Med. 2014 Jan;11(1):113-124. doi: 10.2217/pme.13.94.
- PMID: 29751390
- PubMed abstract
- Source abstract
-
- Mapping Jewish Identities: Migratory Histories and the Transnational Re-Framing of ‘Ashkenazi BRCA Mutations’ in the UK and Brazil.
- Mozersky J, Gibbon S.
- In: Breast Cancer Gene Research and Medical Practices: Transnational Perspectives in the Time of BRCA. Oxon (UK): Routledge; 2014. Gibbon S, Joseph G, Mozersky J, zur Nieden A, Palfner S, editors. Wellcome Trust–Funded Monographs and Book Chapters.
- PMID: 32134615
- PubMed abstract
- Book
- Free Full Text
-
- Medicare slashes payment for BRCA test.
- McCarthy M.
- BMJ. 2013 Dec 31;347:f7709. doi: 10.1136/bmj.f7709.
- PMID: 24381237
- PubMed abstract
- Source abstract
-
- A Myriad of Choices: How the Supreme Court’s Decision Has Affected Clinical Practice.
- Kristen Hanson.
- Perspectives in Genetic Counseling. 35(4):6-7. 2013 Qtr 4.
- News
- Free Full Text
-
- Educational needs and preferred methods of learning among Florida practitioners who order genetic testing for hereditary breast and ovarian cancer.
- Cragun D, Besharat AD, Lewis C, Vadaparampil ST, Pal T.
- J Cancer Educ. 2013 Dec;28(4):690-7. doi: 10.1007/s13187-013-0525-6.
- PMID: 23884548
- PubMed abstract
- Source abstract
-
- Supreme Court Ruling Broadens BRCA Testing Options.
- Azvolinsky A.
- J Natl Cancer Inst. 2013 Nov 20;105(22):1671-2. doi: 10.1093/jnci/djt342. Epub 2013 Nov 6.
- PMID: 24198329
- PubMed abstract
- Source abstract
- News
- Free Full Text
-
- The "New" Genetic Testing: What You Need to Know.
- Rebecca Sutphen.
- FORCE. Be Empowered Webinars. 2013 Nov 18.
- Webinar
- Free video
-
- Pros and cons of screening for BRCA mutations.
- Howard-McNatt M.
- N C Med J. 2013 Nov-Dec;74(6):489-90.
- PMID: 24316772
- PubMed abstract
-
- Quest to offer genetic test for breast cancer risk.
- Bill Berkrot.
- Yahoo! News. Reuters. 2013 Oct 15.
- News
- Free Full Text
-
- Can Unknown Predisposition in Familial Breast Cancer be Family-Specific?
- Lynch H, Wen H, Kim YC, Snyder C, Kinarsky Y, Chen PX, Xiao F, Goldgar D, Cowan KH, Wang SM.
- Breast J. 2013 Sep;19(5):520-8. doi: 10.1111/tbj.12145. Epub 2013 Jun 26.
- PMID: 23800003
- PubMed abstract
- Source abstract
-
- Allocation of work activities in a comprehensive cancer genetics program.
- Mahon SM.
- Clin J Oncol Nurs. 2013 Aug 1;17(4):397-404. doi: 10.1188/13.CJON.397-404.
- PMID: 23899978
- PubMed abstract
- Source abstract
-
- Practical aspects of genetic counseling in breast cancer: Lights and shadows.
- Christinat A, Pagani O.
- Breast. 2013 Aug;22(4):375-82. doi: 10.1016/j.breast.2013.04.006. Epub 2013 May 11.
- PMID: 23673076
- PubMed abstract
- Source abstract
-
- Genetic counseling for breast cancer risk: how did we get here and where are we going?
- Lang KA.
- Expert Rev Mol Diagn. 2013 Jul;13(6):541-51. doi: 10.1586/14737159.2013.811903.
- PMID: 23895125
- PubMed abstract
- Source abstract
-
- Implementation of a breast cancer genetic service in South Africa - lessons learned.
- Schoeman M, Apffelstaedt JP, Baatjes K, Urban M.
- S Afr Med J. 2013 Jun 25;103(8):529-33. doi: 10.7196/samj.6814.
- PMID: 23885733
- PubMed abstract
- Source abstract
-
- Myriad BRCA Patents Nixed: What Happens Next?
- Roxanne Nelson.
- Medscape Medical News. Oncology. 2013 Jun 21.
- News
- Free Full Text
-
- The Angelina effect.
- Kluger J, Park A.
- Time. 2013 May 27;181(20):28-33.
- PMID: 24044164
- PubMed abstract
- Source
-
- Angelina Jolie's Mastectomy: BRCA Testing in the Spotlight.
- Kate Johnson.
- Medscape Medical News. Oncology. 2013 May 16.
- News
- Free Full Text
-
- Myriad to Replace BRACAnalysis, Other Hereditary Cancer Tests with MyRisk Panel.
- [No author given]
- GenomeWeb. 2013 May 9.
- News
- Free Full Text
-
- Opportunities for public health communication, intervention, and future research on breast cancer in younger women.
- Buchanan N, Roland KB, Rodriguez JL, Miller JW, Fairley T.
- J Womens Health (Larchmt). 2013 Apr;22(4):293-8. doi: 10.1089/jwh.2012.4239. Epub 2013 Mar 20.
- PMID: 23514347
- PubMed abstract
- Source abstract
-
- [New genetic tests and their clinical utility for cancer screening].
- Probst-Hensch NM, Brand A.
- Ther Umsch. 2013 Apr;70(4):251-4; discussion 255-6. doi: 10.1024/0040-5930/a000397.
- PMID: 23535553
- PubMed abstract
- Source abstract
-
- Breast Cancer Genetic Testing Gets Covered by Health Care Reform.
- Rachael Rettner.
- Yahoo. MyHealthNewsDaily. 2013 Mar 6.
-
- Improving mutation notification when new genetic information is identified in research: a trial of two strategies in familial breast cancer.
- Wakefield CE, Thorne H, Kirk J, Niedermayr E, Doolan EL, Tucker K.
- Genet Med. 2013 Mar;15(3):187-94. doi: 10.1038/gim.2012.115. Epub 2012 Sep 13.
- PMID: 22975758
- PubMed abstract
- Source abstract
-
- Proposed roadmap to stepwise integration of genetics in family medicine and clinical research.
- Houwink EJ, Sollie AW, Numans ME, Cornel MC.
- Clin Transl Med. 2013 Feb 16;2(1):5. doi: 10.1186/2001-1326-2-5.
- PMID: 23415259
- PubMed abstract
-
- Whole Exome Sequencing Suggests Much of Non-BRCA1/BRCA2 Familial Breast Cancer Is Due to Moderate and Low Penetrance Susceptibility Alleles.
- Gracia-Aznarez FJ, Fernandez V, Pita G, Peterlongo P, Dominguez O, de la Hoya M, Duran M, Osorio A, Moreno L, Gonzalez-Neira A, Rosa-Rosa JM, Sinilnikova O, Mazoyer S, Hopper J, Lazaro C, Southey M, Odefrey F, Manoukian S, Catucci I, Caldes T, Lynch HT, Hilbers FS, van Asperen CJ, Vasen HF, Goldgar D, Radice P, Devilee P, Benitez J.
- PLoS One. 2013;8(2):e55681. doi: 10.1371/journal.pone.0055681. Epub 2013 Feb 8.
- PMID: 23409019
- PubMed abstract
-
- Interest and attitudes of patients, cancer physicians, medical students and cancer researchers towards a spectrum of genetic tests relevant to breast cancer patients.
- Ngoi N, Lee SC, Hartman M, Khin LW, Wong A.
- Breast. 2013 Feb;22(1):47-52. doi: 10.1016/j.breast.2012.04.003. Epub 2012 May 4.
- PMID: 22560561
- PubMed abstract
- Source abstract
-
- Determination of Molecular Markers for BRCA1 and BRCA2 Heterozygosity Using Gene Expression Profiling.
- Salmon AY, Salmon-Divon M, Zahavi T, Barash Y, Levy-Drummer RS, Jacob-Hirsch J, Peretz T.
- Cancer Prev Res (Phila). 2013 Feb;6(2):82-90. doi: 10.1158/1940-6207.CAPR-12-0105. Epub 2013 Jan 22.
- PMID: 23341570
- PubMed abstract
- Source abstract
Research News:
New test predicts BRCA1 and BRCA2 mutations.
- PMID: 23580958
- PubMed abstract
- Source abstract
Press: The Future of BRCA1/BRCA2 Testing. (OncLive)
-
- A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.
- Hoskins LM, Werner-Lin A.
- J Genet Couns. 2013 Feb;22(1):27-38. doi: 10.1007/s10897-012-9521-y. Epub 2012 Aug 3.
- PMID: 22864682
- PubMed abstract
- Source abstract
- Case report
- Free PMC article
-
- Personal genomic testing as part of the complete breast cancer risk assessment: a case report.
- Riordan S, Rodriguez DF, Kieran S.
- J Genet Couns. 2012 Oct;21(5):638-44. Epub 2012 May 19.
- PMID: 22610652
- PubMed abstract
- Source abstract
-
- Lack of BRCA testing approval creates snag for cancer trials.
- Azvolinsky A.
- Nat Med. 2012 Sep 7;18(9):1310. doi: 10.1038/nm0912-1310a.
- PMID: 22961142
- PubMed abstract
- Source abstract
-
- Folate and breast cancer: what about high-risk women?
- Kotsopoulos J, Kim YI, Narod SA.
- Cancer Causes Control. 2012 Sep;23(9):1405-20. doi: 10.1007/s10552-012-0022-y. Epub 2012 Jul 6.
- PMID: 22767328
- PubMed abstract
- Source abstract
-
- Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women.
- Mays D, Sharff ME, Demarco TA, Williams B, Beck B, Sheppard VB, Peshkin BN, Eng-Wong J, Tercyak KP.
- Fam Cancer. 2012 Sep;11(3):493-502. doi: 10.1007/s10689-012-9541-7.
- PMID: 22711611
- PubMed abstract
- Source abstract
-
- [Genetic diagnosis of familial breast cancer].
- Matsuzaki M, Katagata N, Nomizu T.
- Nihon Rinsho. 2012 Sep;70 Suppl 7:238-42.
- PMID: 23350399
- PubMed abstract
-
- Genetic testing by cancer site: breast.
- Shannon KM, Chittenden A.
- Cancer J. 2012 Jul-Aug;18(4):310-9. doi: 10.1097/PPO.0b013e318260946f.
- PMID: 22846731
- PubMed abstract
- Source abstract
-
- Genetic testing by cancer site: ovary.
- Weissman SM, Weiss SM, Newlin AC.
- Cancer J. 2012 Jul-Aug;18(4):320-7. doi: 10.1097/PPO.0b013e31826246c2.
- PMID: 22846732
- PubMed abstract
- Source abstract
-
- Three cases of kindred with familial breast cancer in which carrier detection by BRCA gene testing was performed on family members.
- Nomizu T, Sakuma T, Yamada M, Matsuzaki M, Katagata N, Watanabe F, Nihei M, Ishioka C, Takenoshita S, Abe R.
- Breast Cancer. 2012 Jul;19(3):270-4. doi: 10.1007/s12282-009-0157-1. Epub 2009 Oct 6.
- PMID: 19806429
- PubMed abstract
- Source abstract
-
- Implementation and outcomes of a multidisciplinary high-risk breast cancer program: the William Beaumont Hospital experience.
- Shah C, Berry S, Dekhne N, Lanni T, Lowry H, Vicini F.
- Clin Breast Cancer. 2012 Jun;12(3):215-8. doi: 10.1016/j.clbc.2012.03.002. Epub 2012 Apr 14.
- PMID: 22503234
- PubMed abstract
- Source abstract
-
- Psychological Distress with Direct-to-Consumer Genetic Testing: A Case Report of an Unexpected BRCA Positive Test Result.
- Dohany L, Gustafson S, Ducaine W, Zakalik D.
- J Genet Couns. 2012 Jun;21(3):399-401. Epub 2012 Jan 21.
- PMID: 22271377
- PubMed abstract
- Source abstract
-
- Screening for gynaecologic cancers in genetically predisposed women.
- Dreyer G.
- Best Pract Res Clin Obstet Gynaecol. 2012 Apr;26(2):267-82. doi: 10.1016/j.bpobgyn.2011.11.002. Epub 2012 Feb 22.
- PMID: 22361688
- PubMed abstract
- Source abstract
-
- [Present status and tasks for genetic testing and risk-reducing surgery in patients with hereditary breast and ovarian cancer].
- Arai M, Taki K, Iwase H, Takizawa K, Nishimura S, Iwase T.
- Gan To Kagaku Ryoho. 2012 Apr;39(4):525-31.
- PMID: 22504676
- PubMed abstract
- Source abstract
-
- Differences in US healthcare coverage policies in BRCA testing and potential implications.
- Beattie MS, Wang G, Phillips KA.
- Per Med. 2012 Jan;9(1):5-8. doi: 10.2217/pme.11.85.
- PMID: 29783285
- PubMed abstract
- Source abstract